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ABSTRACT 
JINRONG LIU:  SYNTHESIS, CHARACTERIZATION AND APPLICATIONS  
OF NEW PHOTOCURABLE AND BIODEGRADABLE ELASTOMERS 
 
(Under the direction of Dr. Valerie V.S. Ashby and Dr. Ed T. Samulski) 
 
Biodegradable elastomers have attracted a great deal of interest due to their potential 
applications in the biomedical field. Based on the advantages of the photocuring method, a 
new series of photocurable and biodegradable elastomers were designed. By using step 
growth polymerization, polyester liquids with different composition and molecular weights 
were synthesized. After endcapping with methacrylate groups, these liquids can be easily 
fabricated into completely amorphous elastomers by UV exposure for 1 min at room 
conditions. The prepared elastomers presented a wide range of mechanical properties (G = 
0.1-10 MPa) and a fast degradation rate (16% after 5 week incubation in PBS). The in vitro 
and in vivo biocompatibility studies of the elastomers indicated that these elastomers were 
good candidates as tissue engineering scaffolds. Meanwhile, the functionality of these 
photocurable elastomers was expanded by incorporation of amine containing monomers, and 
new elastomers were prepared to explore their potential as drug carrier systems.  
Monodispersed elastomeric particles were fabricated out of these amine containing materials 
by PRINTTM technology. These particles showed pH sensitive drug release of Doxorubicin (a 
hydrophobic drug model) and Minocycline chloride (a hydrophilic drug model), and the 
release profiles can be further tuned by the incorporation of a disulfide crosslinker.  
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An elastomer is a polymer that exhibits enormous extensibility up to several 
hundred percent, compared with a few percent for ordinary solids, and has the ability to 
recover its original shape and dimensions on release of stress. These materials can be 
covalently crosslinked or connected in a network by physical associations such as small 
crystalline domains.1 Because of their special mechanical properties, elastomers have 
been broadly applied in industry. For example, they have been used as auto tires, 
conveyor belts, footwear, cables, etc. Elastomers have been important materials for the 
development of biomedical engineering and have been used as gloves, catheters, and 
hand and foot joint replacements.2 In tissue engineering, elastomeric scaffolds have been 
used to support and orient cell growth for the generation of replacement tissue. The 
mechanical properties of the elastomer are designed to resemble soft tissues, thereby 
withstanding repeated dynamic loads without causing mechanical stimuli to the 
surrounding tissues. 
There are two categories of elastomers: thermoplastic elastomers and thermoset 
elastomers. Thermoplastic elastomers, which are elastomeric at the use temperatures, are 
physically crosslinked block copolymers, where one block of the copolymer chains 
aggregate to form glassy domains and effectively crosslink the soft segments. Because 
physical crosslinking is reversible upon heating and cooling, thermoplastic elastomers are 
less dimensionally and thermally stable than their thermoset counterparts. Thermoset 
elastomers are formed by the chemical crosslinking of polymer chains, which is an 
irreversible process. These materials are increasingly used in engineering applications 
because of their excellent stability at elevated temperatures and under physical stress. 
They are dimensionally stable under a wide variety of conditions due to their rigid 
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network structure and will not flow when heated.3 Therefore, thermoset elastomers have a 
performance advantage over thermoplastic elastomers, although the latter presents lower 
processing costs. 
Many kinds of elastomers have been studied to date, and this chapter will focus 
on synthetically fabricated elastomers, especially those designed to be biodegradable for 
medical applications. The essential reason for interest in biodegradable materials is the 
desire to have a device that can be used as an implant and does not require a second 
surgical procedure for removal.  
This chapter will be divided into two sections. In the first section, representative 
synthetic methods used for making biodegradable thermoplastic elastomers and 
thermoset elastomers will be reviewed with an emphasis on thermoset elastomers, as they 
can maintain structural integrity upon implantation inside body.1 In the second section, 
the applications of these materials in the biomedical field, especially as scaffolds and 
drug release carriers will be discussed. 
 
1.1 Synthesis of biodegradable elastomers 
1.1.1 Synthesis of biodegradable thermoplastic elastomers (TPE) 
 
Biodegradable thermoplastic elastomers can be prepared as diblock, triblock or 
multiblock copolymers. Generally diblock and triblock copolymers can self-organize into 
well-defined morphologies while multiblock copolymers microphase-separate into less-
defined phases.4 
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Many biodegradable diblock and triblock copolymers have been reported in the 
literature.4-12 Generally one block is formed first with reactive endgroups, followed by the 
formation of alternate blocks. Depending on the composition of the polymer chains, the 
block copolymers can be A-B diblocks8,9, A-B-A triblocks4,10,11 or A-B-C triblocks12. 
Multiblock copolymers can be synthesized by chain extending low molecular weight 
prepolymers.13-22  
Herein, representative examples of these elastomers, their synthesis and the 
corresponding mechanical and thermal properties will be discussed.  
 
1.1.1.1 A-B diblock copolymers 
 
Moon Suk Kim et al. used living cationic polymerization to prepare 
poly(isobutylene-b-ε-caprolactone) diblocks for making biodegradable thermoplastic 
elastomer (Scheme 1-1).9 This new synthetic method involved the combination of living 
cationic polymerization of isobutylene and living cationic ring-opening polymerization of 
ε-CL. These synthetic conditions afforded well-defined poly(isobutylene-b-ε-
caprolactone) diblock without unfavorable backbiting or transesterification reactions. 
This simple methodology yielded a thermoplastic elastomer with a semicrystalline, 
biodegradable end segment. Tg and Tm were found to be -60 °C and 60 °C, respectively.  
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Figure 1-1. Living cationic polymerization preparation of poly(isobutylene-b-ε-
caprolactone) diblocks by Moon Suk Kim et al. 
 
 
1.1.1.2 A-B-A triblock copolymers 
 
A more effective network formation can be achieved by A-B-A triblock 
copolymers. Hiki et al. reported a telechelic poly([RS]-3-hydroxybutyrate) prepared using 
the ring-opening polymerization of [RS]-b-butyrolactone and 1,4-butanediol as the 
initiator (Figure 1-2).7 The subsequent copolymerization with L-lactide afforded highly 
elastomeric A-B-A type triblock copolyesters. The Young’s modulus of the copolymer 
films increased from 30 to 160 MPa and the elongation at break decreased from 200 to 
86% with increasing PLLA composition (44-69%) and increasing crystallinity (9-23%). 
The Tg values ranged from 15-47 ºC.  
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Figure 1-2. Ring-opening polymerization [RS]-b-butyrolactone in the presence of 1,4-
butanediol and copolymerization with L-lactide by Hiki et al. 
 
 
1.1.1.3 A-B-C triblock copolymers 
 
Elisa Zini et al. prepared novel (L-lactide-glycolide-trimethylene carbonate) 
terpolymers via sequential ring-opening polymerization of the cyclic monomers using 
low-toxicity zirconium (IV) acetylacetonate as the initiator (Figure 1-3).12 The glass 
transition temperature of the terpolymers ranged from 12 to 42 ºC, and the Young's 
modulus ranged from 3-1541 MPa. The obtained polymers showed shape memory 
properties, which can reform to their original shapes, and they recovered the permanent 
shape near body temperature. This property be beneficial in minimally invasive surgery. 
The combination of low toxicity and shape memory properties made the triblock 
copolymers promising for biomedical applications. 
  7 
 
Figure 1-3. Novel (L-lactide-glycolide-trimethylene carbonate) terpolymers by Elisa Zini 
et al. 
 
1.1.1.4 Multiblock thermoplastic elastomers 
 
Polyurethanes are the most prevalent class of multiblock thermoplastic 
elastomers.13-22 Low molecular weight polyesters are used as the soft segments to yield 
biodegradable polyurethanes. Cohn et al. synthesized PCL/PLA thermoplastic elastomers, 
where poly(L-lactic acid) generated the hard blocks and poly(caprolactone) created the 
soft segments along the copolymeric backbone with hexamethylene diisocyanate as a 
chain extender. This led to a family of biodegradable poly(ester-urethane) multiblock 
copolymers.19 The multiblock copolymers displayed enhanced mechanical properties, 
with ultimate tensile strength values near 32 MPa, Young’s modulus as low as 30 MPa 
and elongation at break values well above 600% (Figure 1-4). These copolymers 
exhibited Tg values approximately -30 °C and Tm values near 42 °C. 
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Figure 1-4. Synthesis and structure of PCLA multiblock copolymers by Cohn et al. 
 
In addition to poly(ester-urethane)s, poly(urethane urea)s have also been explored 
to afford better mechanical properties. 21,22 Guan et al. synthesized a family of 
biodegradable poly(ester-urethane)ureas based on poly(caprolactone) and butyl 
diisocyanate. The polymers were highly flexible, with tensile strengths ranging from 9.2 
to 29 MPa and breaking strains from 660 to 895% (Figure 1-5).22 They further improved 
the hydrophilicity and biodegradation rate of the poly(urethane)urea by later 
incorporation of polyethylene glycol.23, 24  
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Figure 1-5. Synthesis of poly (ester urethane)urea (PEUU) by Guan et al. 
 
As can be seen from the above examples, a wide variety of thermoplastic 
elastomers can be prepared by tuning the block composition and distribution. Since the 
elasticity of thermoplastic elastomers comes inherently from the phase separation of 
crystalline and amorphous regions. Once the elastomers are implanted inside body, the 
two regions will hydrolyze at different rates, and as such, the elastomers degrade 
heterogeneously resulting in a nonlinear loss of strength, which will deform the original 
designed structure.19 However, completely amorphous thermoset elastomer materials will 
degrade more homogenously with a more linear degradation of physical properties, 
making them more desirable in tissue engineering scaffolds.40 
 
1.1.2 Synthesis of biodegradable thermoset elastomers 
 
 The most common method used in the literature to fabricate biodegradable 
thermoset elastomers begins with prepolymer preparation with curable functional groups 
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that are located on the polymer backbone or on the chain ends. Three dimensional 
networks can be formed from these prepolymers using irreversible thermal curing or 
photocuring methods.25-40  
 
1.1.2.1 Thermally crosslinked elastomers via ring-opening polymerization 
 
Storey et al. synthesized a series of 3-arm poly(D,L-lactide-co-trimethylene 
carbonate) prepolymers (Figure 1-6).36,37 The prepolymers were free radically crosslinked 
in the absence of reactive diluents to give amorphous, bioabsorbable networks with a 
broad range of thermal, mechanical and degradation properties. The sol content in the 
elastomers ranged from 2.87% to 6.17%.  Tensile tests showed that the stress ranged 
from 3 to 60 MPa and strain was 5-55%. The degradation rate was dependent on the ratio 
of the two components, and the prepolymer of DLL:TMC = 40:60 gave the most uniform 
degradation rate in terms of strength loss with a mass loss of 4% after 119 days 
incubation in PBS at 37 ºC.  
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Figure 1-6. Synthesis of poly(D,L-lactide), poly(D,L-lactide-co-trimethylene carbonate) 
and poly(trimethylene carbonate) triols by Storey et al. 
 
1.1.2.2 Thermally crosslinked elastomers via step growth polymerization 
 
Another broadly used synthetic scheme to fabricate biodegradable thermoset 
elastomers is polycondensation of multifunctional carboxylic acids and polyols.25,29,41,42 
In this approach, small molecule by-products are produced and removed typically using 
high vacuum to drive the reaction forward.  Compared with ring-opening polymerization, 
which suffers from a limited supply of cyclic monomers, making it more difficult to tune 
the properties for different application requirements, step growth polymerization can 
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easily incorporate a wide variety of monomers into the synthetic schemes, affording the 
ability to expand the properties of the elastomers.43,44 
Multifunctional monomers are widely employed to fabricate thermally 
crosslinked elastomers. Kiyotsukuri et al. was one of the first to fabricate a thermally 
crosslinked network by using glycerol and a wide range of diacids at high temperatures 
(Figure 1-7) to prepare thermoset elastomers.45 Prepolymers were first synthesized and 
successively post-polymerized to form the networks. The resultant films were 
transparent, flexible and insoluble in organic solvents. The Young’s modulus ranged 
from 7-28 MPa with ultimate strains ranging from 13-30 %, and the Tg ranged from -50 
ºC to -3 ºC. 
 
Figure 1-7. Elastomer preparation via polycondensation by Kiyotsukuri et al. 
The same monomers were used by Langer’s group to fabricate a softer 
biodegradable elastomer as scaffolds for soft tissue replacement.25 They chose a lower 
reaction temperature (120 ºC) and a longer reaction time (24 h) to synthesize the 
prepolymer from sebacic acid and glycerol. An almost colorless elastomer was formed by 
further fabrication using heat and vacuum. DSC data showed two crystallization 
temperatures at -52.14 °C and -18.50 °C and two melting temperatures at 5.23 °C and 
37.62 °C, respectively. The Young's modulus of the polymer is 0.282 ± 0.0250 MPa, 
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indicating a soft material with 267 ± 59.4 % strain and ultimate tensile strength > 0.5 
MPa.  
The multifunctional monomer methodology was improved by Ameer’s group to 
prepare totally amorphous thermoset elastomers.26,41 The synthesis was similar to 
Kiyotsukuri’s approach but with citric acid used as the crosslinking agent instead of 
glycerol. Poly(diol citrate)s were synthesized by reacting citric acid with various diols to 
form a covalent crosslinked network via a polycondensation reaction without the use of a 
catalyst (Figure 1-8). The tensile strengths of the poly(diol citrate)s were as high as 11.15 
± 2.62 MPa, and Young's modulus ranged from 1.60 ± 0.05 MPa to 13.98 ± 3.05 MPa. 
Elongation was as high as 502 ± 16%. Glass transition temperatures (Tg) for all poly (diol 
citrate) thermosets were from −5 to 10 °C. No melting peaks or crystallization peaks were 
observed.  
 
Figure 1-8. Poly(diol citrate)s preparation via polycondensation by Ameer et al. 
 
However, multifunctional approaches suffer from a lack of ability to vary 
properties by controlling the crosslinking chemistry. Instead of the multifunctional 
monomer approach, many researchers chose free radical curing of the prepolymers to 
fabricate biodegradable elastomers. In this strategy, unsaturated groups are incorporated 
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in the prepolymers either on the backbone, as grafts or at the chain ends. Sheares et al. 
chose an unsaturated acid, hydromuconic acid, to react with poly(ethylene glycol) 
oligomers (Figure 1-9).46 Completely amorphous, liquid poly (ester ether) prepolymers 
with number average molecular weights between 4 and 6 x 103 g/mol were prepared via 
condensation polymerization. These liquid prepolymers were then thermally crosslinked 
to form degradable elastomeric structures with glass transition temperatures below -30°C. 
Materials could be designed to completely degrade in vitro over a range of 30 days to 6 
months, while the Young’s modulus could be varied over 3 orders of magnitude (0.02-20 
MPa). These prepolymers could not be photocured due to the low activity of the vinyl 
groups in the middle of the polymer backbones. 
 
 
Figure 1-9. Synthesis of unsaturated poly(ester ether) A) prepolymers and B) copolymers 
by Sheares et al. 
 
Although thermal crosslinking can afford totally amorphous thermoset 
elastomers, there are several disadvantages for this approach, as high temperatures (90–
250 ºC) and long fabrication times (24 h to several days) are normally required. Another 
widely used approach to fabricate thermoset elastomers is to photo crosslink the network, 
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which leads to the material preparation in several minutes at room temperature with 
better spatial and temporal control. 
 
1.1.2.3 Photocurable elastomers via ring-opening polymerization 
 
Preparing unsaturated groups at the end of prepolymer chains is a broadly used 
method to make photocurable elastomers.47-50 This strategy is popular because terminal 
double bonds are more reactive than those along the backbone, allowing more efficient 
network formation. And also, this method allows wide selection of monomers. 
Anseth et al. prepared methacryloyl terminated poly(lactic acid-co-caproic acid) 
diethylene glycol based oligomers to explore new scaffold system for tissue engineering 
application by systematic chemical variations in the degradable block of the crosslinked 
network (Figure 1-10).49 These macromers were then photo polymerized at 450 nm to 
produce crosslinked degradable networks. The prepolymer molecular weights ranged 
from 1.6-2.3 x 103 g/mol, and the methacrylation efficiency was 70-100%. They found 
the storage modulus was on the order of 10-103 MPa, and Tgs ranged from -30 to 56 °C.  
Complete degradation occurred in as short as 80 days to more than 6 months.  
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Figure 1-10. Synthesis of diethylene glycol/α-hydroxy acid copolymer containing photo 
polymerizable end groups by Anseth et al. 
The ring-opening polymerization approach was extensively explored by Amsden 
and his co-workers.38-40 Star polyesters of ε-caprolactone-co-D,L-lactide were prepared 
by ring-opening polymerization, which was initiated by glycerol.  After endcapping with 
acrylate groups, UV light was used to crosslink the system (Figure 1-11). The influence 
of the prepolymer molecular weight on the mechanical properties and thermal properties 
was determined. The glass transition temperature of the elastomers was independent of 
the prepolymer molecular weight and was from -6 to -8 ºC. The Young’s modulus (G = 
0.5-5.4 MPa) and stress at break (σ = 1.2-4.5 MPa) of the elastomers was inversely 
proportional to the prepolymer molecular weight, while the strain at break increased in a 
linear fashion with the prepolymer molecular weight.  
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Figure 1-11. Synthesis of polyesters of ε-caprolactone-co-D,L-lactide by Amsden et al.  
 
1.1.2.4 Photocurable elastomers via step growth polymerization 
 
Minoru Nagata et al. reported photocurable and biodegradable multiblock 
copolymers by step growth polymerization of poly(ε-caprolactone) (PCL) diols and 
poly(ethylene glycol) (PEG) with 4,4’-(adipoyldioxy)dicinnamic dichloride as a chain 
extender (Figure 1-12). These copolymers were chosen to explore new shape memory 
materials with outstanding properties such as hydrophilicity, permeability, and 
degradability.51,52 Glass transition temperatures ranged from -64 to -62 ºC, and melting 
temperature were from 34 to 48 ºC. The stress at break ranged from 3.1-4.7 MPa, and 
elongation at break ranged from 640-1500%. The materials recovered very rapidly to the 
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original size from 90-300% extension. The rate of degradation could be tuned by the ratio 
of PEG components. This approach needed long irradiation time to attain high crosslink 
density. Moreover, the elastomers were not fully amorphous. 
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Figure 1-12. Preparation of polyesters derived from CAC, poly(ethylene glycol) diol and 
poly(ε-caprolactone) diol by Minoru Nagata et al. 
 
1.1.3 General requirements for materials design 
 
  19 
The previous examples described a wide variety of methods to develop 
biodegradable elastomers suitable for biomedical applications. While these elastomers 
have a wide range of properties and dramatically advanced the field of biomaterials 
science, there is still significant room for improvement. At this point, there are several 
properties that need to be further developed or optimized. 
 
 Soft materials: Prepare materials that can be used for soft tissue replacement. 
 Totally Amorphous: Prepare materials that can maintain the structural 
integrity over the use range. 
 Photocurable: Prepare materials that with less energy consumption and better 
spatial and temporal control. 
 Synthetically Ease: Prepare materials using a minimal number of synthetic 
steps and less post polymerization steps that can potentially degrade the 
material. 
 Tailorable Properties: Develop synthetic methods that allow for the 
properties of the material to be easily modified with fine precision. 
 Biocompatibility: Develop new materials with a reduced foreign body 
response. 
 Biodegradability: Tailor the time span in which a material degrades over a 
broad range. 
 
1.2 Biomedical applications of biodegradable elastomers 
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Biodegradable elastomers have received a great deal of interest in the biomedical 
field due to their suitable mechanical properties and degradation profiles. They have been 
extensively explored in the fields of tissue engineering and drug release systems.30 The 
following discussion will focus on these two areas. 
1.2.1 Biodegradable elastomers in tissue engineering 
As the understanding of mechanical stimulation in the engineering of elastic soft 
tissues develops, appropriate biodegradable elastomers can be designed to meet these 
specifications (withstanding repeated dynamic loads, providing a cell attachment surface 
and limited irritation to the surrounding tissues). After a period of application, they can 
totally degrade without a second surgery requirement. When used in the tissue 
engineering field, the elastomers can be either serve as a functional coating53,54 to modify 
other biomaterials or as scaffolds themselves.55-58 
 
1.2.1.1 Modification for nondegradable materials 
 
Yang et al. used poly(octanediol citrate)-based biodegradable elastomers (POC) 
to modulate expanded polytetrafluoroethylene (ePTFE) vascular graft, which is broadly 
used as large diameter blood vessels. They are not applicable to small diameter blood 
vessels (SDBV) due to the poor patency resulting from compliant mismatch to local 
tissues.53 Due to the elastomeric nature of POC, POC coating on ePTFE (POC-ePTFE) 
significantly changed the surface energy of the ePTFE grafts without affecting graft 
compliance, which allows it to mobilize according to the expansion or contraction of the 
ePTFE fibrils when the graft is exposed to pulsatile flow conditions (Figure 1-13). POC 
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modification significantly improved the hemocompatibility and acute inflammatory 
response of ePTFE grafts implanted in a porcine iliac artery ePTFE bypass model. 
 
 
 
 
 
 
 
Figure 1-13. A) Effect of the POC coating on the compliance of graft. Compliance of the 
control ePTFE grafts and POC-ePTFE grafts with 1 coating (1 C) and 3 coatings (3 C).   
B) Platelet adhesion on ePTFE, POC, POC-ePTFE, and glass by Yang et al. 
 
1.2.1.2 Nonporous Scaffolds 
 
Biodegradable elastomers have been extensively studied as scaffolds in tissue 
engineering. Depending on their specific applications, the scaffolds can be fabricated to 
be nonporous or porous. Figure 1-14 shows some examples of nonporous scaffolds 
fabricated from poly(glycerol sebacate) based elastomers: microfluidic channels, grooved 
surface, micropatterned scaffolds and a block scaffold.56,59-66 Different cell lines have 
been explored: primary baboon vascular cells, retinal progenitor cells, endothelial 
progenitor cells, Schwann cells, indicating the potential applications in nerve, 
cardiovascular, myocardium and vascular tissue engineering. The in vitro and in vivo 
degradation properties have been fully explored and it showed that the elastomers were 
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biocompatible and had better geometric stability than the commercial PLGA based 
biomaterials.         
     
      
      
                D     
Figure 1-14. Poly(glycerol sebacate) based elastomers. A) PGS capillary networks, B) 
PGS grooved surface, C) PGS micropatterned scaffold, D) PGS block (ref 56,59-66) 
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Fujii et al. combined MEMS technology and biology together to fabricate 
microchambers and microchannels from acrylated poly(caprolactone-L-lactide) 
copolymers, which mimicked the in vivo microenvironment for cell behavior and 
explored their application in tissue engineering.67 Various single and multistepwise 
microstructures were achieved by this soft lithography method (Figure 1-15). 
Microstructures down to 50 micron were fabricated for liver reconstructs.  They 
investigated various mammalian cells growth and spreading in these implantable 
bioreactors.  Static cultures of multiple cell lines could be successfully performed on 
single stepwise microstructures. Both cell culture and perfusion experiments suggested 
the possibility to use the present photosensitive polymer as microfluidic supports for 
biodegradable bioreactors for implantation applications. 
 
 
 
 
 
Figure 1-15. Various single and multistepwise microstructures were achieved by soft 
lithography method, A) single microstructure, scare bar = 200 µm, B) single 
microstructure, scare bar = 500 µm and C) multistepwise microstructure, scare bar = 500 
µm by Fujii et al. 
 
1.2.1.3 Porous Scaffolds 
 
B CA 200 µm 500 µm 500 µm
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Porous tissue engineering scaffolds are more commonly designed than nonporous 
scaffolds since the interconnected pores can assure cell growth and the transport flow of 
nutrients and metabolic waste. Moreover, the porosity can be tuned to improve the 
mechanical match to the surrounding tissue without fundamental materials modification.1, 
56-58
 Porous scaffolds can be fabricated by different techniques: salt leaching, gas foaming 
from a polymer melt, thermally induced phase separation or nonsolvent induced phase 
separation.68, 69 
Wagner et al. fabricated two kinds of porous scaffolds by thermally induced 
phase separation using dimethyl sulfoxide as a solvent from biodegradable poly(urethane 
urea)s, namely poly(ester urethane)urea and poly(ether ester urethane)urea prepared from 
polycaprolactone, polycaprolactone-b-poly(ethylene glycol)-b-polycaprolactone, and 1,4-
diisocyanatobutane.70 By changing the polymer solution concentration or quenching 
temperature, scaffolds with random or oriented tubular pores were obtained (Figure 1-
16). Smooth muscle cells were filtration seeded into the scaffolds, and it was shown that 
both scaffolds supported cell adhesion and growth.  
 
 
 
 
 
 
Figure 1-16. SEM of PEUU scaffolds prepared from different solution concentrations 
and quenching temperatures, A) 5% and -80 ºC and B) 8% and -20 ºC by Wagner et al. 
A B
  25 
Several techniques can be utilized together to design the specific structures.71,72 
Desai et al. developed porous micro-patterned poly(caprolactone) scaffolds using a novel 
technique that integrated soft lithography, melt molding and particulate leaching of 
polylactic-co-glycolic acid micro/nanoparticles.71 Firstly, PLGA micro/nanospheres were 
prepared for use as a porogen. Secondly, micro-patterned PLGAs were embeded in PCL 
scaffolds with thicknesses on the tens of microns scale by a patterned PDMS mold. 
Lastly, the scaffolds were immersed in a basic solution to rapidly degrade the 
micro/nanospheres. The SEM images of the scaffolds are shown in Figure 1-17. The 
evaluation of nutrient diffusion through the porous scaffolds compared with nonporous 
PCL was conducted by using phenol red as a model. They found that PLGA-leached PCL 
scaffold had more phenol red passing through, indicating improvement for the nutrient 
diffusion. Vascular smooth muscle cells (VSMCs) were seeded on the scaffold to 
investigate the cell alignment on the porous patterned scaffolds. For unpatterned 
nonporous scaffolds, VSMCs showed unorganized and irregular shapes. In contrast, cells 
seeded on patterned PLGA-leached scaffolds appeared in an elongated and organized 
morphology, which indicated that patterned micro/nanospheres scaffolds helped maintain 
alignment. These findings are significant because micropatterning of VSMCs has been 
associated with promoting in vivo like VSMC morphology as well as enhanced ECM 
production and decreased proliferation.73,74  
 
 
 
Figure 1-17. Porous micro-patterned polycaprolactone scaffolds by Desai et al. 
A B C
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As the understanding of the interaction between scaffolds and cells has 
progressed, more scaffolds have been fabricated to directly mimic the shape of target 
organs.75-78 Sodian et al. fabricated a trileaflet heart scaffold from a polyhydroxyalanoate 
elastomer. The trileaflet heart valve scaffold consisted of a cylindrical stent containing 
three valve leaflets formed from a single piece of polyhydroxyalanoate (Figure 1-18).77 
The material was modified by a salt leaching technique to create a porous, three-
dimensional structure. The leaflets opened and closed when tested in a pulsatile flow 
bioreactor, and cells formed a confluent layer after incubation. Later they used an 
advanced stereo lithography technique to fabricate a human aortic root scaffold and a 
pulmonary heart valve scaffold.76 
 
Figure 1-18. A) Crown like porous polyhydroxyalanoate construct, B) Trileaflet heart 
valve scaffold, C) Cell ingrowth into the pores by Sodian et al. 
 
1.2.1.4 Biphasic Scaffolds made from nonporous and porous elastomers 
 
Porous and nonporous structures can be combined together to fabricate more 
advanced scaffolds. An elastic biphasic scaffold was fabricated from POC based 
biodegradable elastomers to mimic small diameter blood vessels (Figure 1-19). 41,55 The 
A B C 
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biphasic scaffold architecture was fabricated by sequential postpolymerization of 
concentric nonporous and porous layers of poly(diol citrate)s. The nonporous phase was 
designed to serve as a continuous surface for endothelial cell adhesion, proliferation, and 
differentiation and to provide mechanical strength and elasticity to the scaffold. The 
porous phase was expected to facilitate the three-dimensional expansion and maturation 
of smooth muscle cell and endothelial cells. Tensile tests, burst pressure, and compliance 
measurements confirmed that the nonporous phase created a “skin” connected to the 
porous phase and provided bulk mechanical properties that were similar to those of a 
native vessel. In vitro culture of tubular biphasic scaffolds seeded with human aortic 
smooth muscle cells and endothelial cells demonstrated the ability of this design to 
support cell compartmentalization, coculture, and cell differentiation. 
 
 
 
 
 
Figure 1-19. A) Photographs of POC scaffolds, B) SEM image of a porous scaffolds, and 
C) SEM of human aortic smooth muscle cell (HASMC) cultured within the porous POC 
scaffold (ref 41,55) 
 
1.2.2 Biodegradable elastomers as drug carrier 
 
There is significant interest in developing biodegradable elastomers as drug 
release systems since the materials are degradable, require no subsequent surgical 
A                        B                    C
  28 
removal and lead to no accumulation inside body. Moreover, the materials are elastic, 
which has special advantages of osmotic pressure-driven in controlled release. Drugs can 
be chemically linked to the polymer chain (bioconjugation) or dispersed in the polymeric 
elastomer system (dispersion).79,80 
 
1.2.2.1 Bioconjugate systems 
 
Leong et al. designed drug-carrying elastomers based on poly(phosphoester-
urethanes) (PPUs) (Figure 1-20).81 The labile phosphoester linkage in the backbone of the 
PPU conferred biodegradability on the polymer. Using the reactive phosphite side chain 
in the PPUs, p-aminosalicylic acid and benzocaine (models of drugs) were attached 
pendantly to the polymer with or without a spacer.  In contrast, ethambutol was 
incorporated into the backbone of the polymer. The drug release was studied from the 
two methods and also the cytotoxicity of the drug carrier. In vitro release of both drugs 
was completed in several hours, indicating the lability of the phosphoramidate bond 
(Figure 1-21). Particles of 1-5 µm size were fabricated from the elastomers, and the 
cytotoxicity was studied against a macrophage cell line. Results indicated healthy cell 
growth and particle uptake by cells.  
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Figure 1-20. Synthesis of poly(phosphoester urethane)s (PPU) s by Leong et al. 
 
 
  
 
 
 
 
 
Figure 1-21.  In vitro release of both drugs by Leong et al. 
 
1.2.2.2 Dispersion systems 
 
Although chemical grafting of drugs on the elastomers was useful for controlled 
drug release, there are limitations for the availability of drugs which can be grafted on the 
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polymer backbone. Moreover, to deliver different drugs, the polymer backbone has to be 
specially redesigned, which is synthetically difficult. The alternative is to directly 
disperse drugs inside the elastomer matrix where a wide selection of drugs and polymer 
systems can be used. 
 Drug dispersed elastomers have been broadly investigated for use in osmotic 
pressure-driven drug release. These materials help to provide a nearly constant release of 
drug for prolonged times because of the elastic properties from the elastomer matrix.82-85  
For example, Ameer et al. fabricated slab-shaped or cylindrical elastomeric 
devices by photocrosslinking an acrylated star copolymer macromer of ε-caprolactone 
and D,L-lactide and tested the elastomer matrix as drug delivery vehicles for interferon-γ 
(IFN-γ), vascular endothelial growth factor (VEGF) and interleukin-2 (IL-2).39,86,87 Under 
identical formulation conditions, these proteins were released at the same, nearly constant 
rate for a significant part of the release profile (until 70%–80% release depending on 
formulation characteristics). Decreasing the molecular weight of the acrylated macromers 
increased the rate of protein release, but did not alter the zero order nature of the release 
kinetics. The bioactivity of released proteins varied with VEGF at 57% bioactivity and 
IL-2 and IFN-γ at 80% bioactivity (Figure 1-22). The elastomer formulation has potential 
as a regiospecific protein delivery device. 
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Figure 1-22. A) Release kinetics and B) percentage of bioactivity of vascular endothelial 
growth factor (VEGF; squares), interferon-γ (IFN- γ, triangles), and interleukin-2 (IL-2; 
circle) from elastomers by Ameer et al. 
 
As can be seen from the above examples, biodegradable elastomers have been 
broadly investigated for biomedical applications and numerous advances have been 
made. However, there is still much room for improvement, such as maintaining the 
structural integrity upon degradation and controlled drug release responsive to the 
surrounding environment. Based on the requirements for scaffolds as soft tissue 
replacement, we designed completely amorphous, photocurable and biodegradable 
elastomers and explored their potential in tissue engineering. At the same time, we took 
advantage of the versatility of step growth polymerization and synthesized pH sensitive 
elastomers and further studied their applications as drug carrier systems.  
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1.3 Dissertation Organization 
This dissertation is organized into five chapters.  
1.                 The first chapter is the general introduction to biodegradable elastomers 
synthesis and application. In the first section, two major types of elastomers, 
biodegradable thermoplastic elastomers and biodegradable thermoset elastomers 
are discussed from various synthetic approaches with corresponding thermal and 
mechanical properties.  In the second section, the applications of biodegradable 
elastomers are illustrated in the tissue engineering and drug delivery fields. This 
discussion is accompanied by fabrication methods and experimental results. 
2.                 The second chapter describes the synthesis and characterization of new 
photocurable and biodegradable elastomers. The synthetic routes are explored and 
thermal, mechanical, surface and degradation properties as well as 
biocompatibility are studied. 
3.                 The third chapter focuses on the in vivo study of the photocurable and 
biodegradable elastomers, including the mechanical change, surface morphology, 
and cell response. 
4.                 The fourth chapter outlines the synthesis and characterization of amine 
functional biodegradable elastomers, fabrication of monodispersed particles and 
exploration of their applications as pH sensitive drug release carriers. 
5.                 The fifth chapter summarizes and describes the future utility for this 
dissertation work. Each chapter is written in the style of a journal paper with its 
own supplemental materials. 
  33 
1.4 Reference 
1. Cordier, P.; Tournilhac, F.; Soulie-Ziakovic, C.; Leibler, L. Nature 2008, 977-980. 
2. Schweitzer, P. A. Mechanical and Corrosion-resistant Properties of Plastics and 
Elastomers, New York Marcel Dekker Inc., 2000. 
 
3. Odian, G. Principles of polymerization. John Wiley & Sons, Inc.: Canada, 1981. 
4. Hiki, S.; Miyamoto, M.; Kimura, Y. Polymer 2000, 20, 7369-7379. 
5. Kissel, T.; Li, Y.; Unger, F. Adv. Drug Delivery. Rev. 2002, 1, 99-134. 
6. Kim, J. H.; LEE, J. H. Polymer J. 2002, 203-208. 
7. Zhang, Z.; Grijpma, D. W.; Feijen, J. J. Control. Release 2006, 2, e29-e31. 
8. Wanamaker, C. L.; O'Leary, L. E.; Lynd, N. A.; Hillmyer, M. A.; Tolman, W. B. 
Biomacromolecules 2007, 11, 3634-3640. 
 
9. Kim, M. S.; Faust, R. Polymer Bulletin 2002, 48, 127-134. 
10. Timbart, L.; Renard, E.; Langlois, V.; Guerin, P. Macromolecular Bioscience 2004, 
11, 1014-1020. 
 
11. Frick, E. M.; Hillmyer, M. A. Macromol. Rapid Commu. 2000, 18, 1317-1322. 
12. Zini, E.; Scandola, M.; Dobrzynski, P.; Kasperczyk, J.; Bero, M. Biomacromolecules 
2007, 11, 3661-3667. 
 
13. Oprea, S.; Vlad, S.; Stanciu, A.; Ciobanu, C.; Macoveanu, M. European Polymer J. 
1999, 7, 1269-1277. 
 
14. Yeganeh, H.; Barikani, M.; Noei Khodabadi, F. European Polymer J. 2000, 10, 2207-
2211. 
 
15. Yeganeh, H.; Shamekhi, M. A. Polymer 2004, 2, 359-365. 
16. Krijgsman, J.; Gaymans, R. J. Polymer 2004, 2, 437-446. 
17. Tatai, L.; Moore, T. G.; Adhikari, R.; Malherbe, F.; Jayasekara, R.; Griffiths, I.; 
Gunatillake, P. A. Biomaterials 2007, 36, 5407-5417. 
 
18. Kim, B. K.; Lee, J. C. J. Polym. Sci. , Part A:Polym. Chem. 1996, 6, 1095-1104. 
  34 
19. Cohn, D.; Hotovely S.A. Biomaterials 2005, 15, 2297-2305. 
20. Kozlowska, A.; Ukielski, R. European Polymer J. 2004, 12, 2767-2772. 
21. Marcos-Fernández, A.; Abraham, G. A.; Valentín, J. L.; Román, J. S. Polymer 2006, 
3, 785-798. 
 
22. Guan, J.; Sacks, M. S.; Beckman, E. J.; Wagner, W. R. J. Biomed. Mater. Res. 2002, 
3, 493-503. 
 
23. Jiang, X.; Li, J.; Ding, M.; Tan, H.; Ling, Q.; Zhong, Y.; Fu, Q. European Polymer J. 
2007, 5, 1838-1846. 
 
24. Guan, J.; Sacks, M. S.; Beckman, E. J.; Wagner, W. R. Biomaterials 2004, 1, 85-96. 
25. Wang, Y.D.; Ameer, G.A.; Sheppard, B.J.; Langer, R. Nat. biotechnol. 2002, 602-
606. 
 
26. Yang, J.; Webb, A. R.; Pickerill, S. J.; Hageman, G.; Ameer, G. A. Biomaterials 
2006, 9, 1889-1898. 
 
27. Anderson, D. G.; Tweedie, C. A.; Hossain, N.; Navarro, S. M.; Brey, D. M.; Vliet, K. 
J.; Langer, R.; Burdick, J. A. adv. mater. 2006, 2614-2618. 
 
28. Helminen, A. O.; Korhonen, H.; Seppälä, J. V. Macromol. Chem. Phys. 2002, 18, 
2630-2639. 
 
29. Ding, T.; Liu, Q.; Shi, R.; Tian, M.; Yang, J.; Zhang, L. Polym Degrad Stab 2006, 4, 
733-739. 
 
30. Amsden, B. Soft Matter 2007, 1335-1348. 
31. Kamber, N. E.; Jeong, W.; Waymouth, R. M. Chem. Rev. 2007, 5813. 
32. Dechy-Cabaret, O.; Martin-Vaca, B.; Bourissou, D. Chem. Rev. 2004, 6147-6176. 
33. Nakayama, A.; Kawasaki, N.; Arvanitoyannis, I.; Iyoda, J.; Yamamoto, N. Polymer 
1995, 6, 1295-1301. 
 
34. Pitt, C. G.; Hendren, R. W.; Schindler, A.; Woodward, S. C. J. Control. Release 
1984, 3-14. 
 
35. Lendlein, A.; Neuenschwander, P.; Ulrich W. Suter, U. W. Macromol. Chem. Phys. 
2000, 1067-1076. 
 
 
  35 
36. Storey, R. F.; Warren, S. C.; Allison, C. J.; Puckett, A. D. Polymer 1997, 26, 6295-
6301. 
 
37. Palmgren, R.; Karlsson, S.; Albertsson, A. J. Polymer Sci. Part A: Polymer Chem. 
1996, 1635-1649. 
 
38. Amsden, B. G.; Misra, G.; Gu, F.; Younes, H. M. Biomacromolecules 2004, 6, 2479-
2486. 
 
39. Gu,F.; Neufeld, R.; Amsden, B. . Pharm. Res 2006, 23, 782-789. 
40. Younes, H. M.; Bravo-Grimaldo, E.; Amsden, B. G. B. G. Biomaterials 2004, 22, 
5261-5269. 
 
41. Yang, J.; Webb, A. R.; Ameer, G. A. Adv. Mater. 2004, 511. 
42. Nijst, C. L. E.; Bruggeman, J. P.; Karp, J. M.; Ferreira, L.; Zumbuehl, A.; Bettinger, 
C. J.; Langer, R. Biomacromolecules 2007, 10, 3067-3073. 
 
43. Albertsson, A.; Varma, I. K. Adv. Polym. Sci 2002, 1-40. 
44. Okada, M. Prog. Polymer Sci. 2002, 87-133. 
45. Kiyotsukuri, T.; Kanaboshi, M.; Tsutsumi, N. Polym. Int. 1994, 1-8. 
46. Olson, D. A.; Gratton, S. E. A.; DeSimone, J. M.; Sheares, V. V. J. Am. Chem. Soc. 
2006, 41, 13625-13633. 
 
47. John, G.; Morita, M. Macromolecules 1999, 6, 1853-1858. 
48. Storey, R. F.; Warren, S. C.; Allison, C. J.; Wiggins, J. S.; Puckett, A. D. Polymer 
1993, 20, 4365-4372. 
 
49. Davis, K. A.; Burdick, J. A.; Anseth, K. S. Biomaterials 2003, 14, 2485-2495. 
50. Shen, J. Y.; Pan, X. Y.; Lim, C. H.; Chan-Park, M. B.; Zhu, X.; Beuerman, R. W. 
Biomacromolecules 2007, 2, 376-385. 
 
51. Nagata, M.; Sato, Y. Polymer 2004, 1, 87-93. 
52. Nagata, M.; Kitazima, I. Colloid & Polymer Sci. 2006, 380-386. 
53. Yang, J.; Motlagh, D.; Allen, J. B.; Webb, A. R.; Kibbe, M. R.; Aalami, O.; Kapadia, 
M.; Carroll, T. J.; Ameer, G. A. Adv. Mater. 2006, 12, 1493-1498. 
 
54. Ruane, P. H. US Patent 20070196423, Aug, 2007. 
  36 
55. Yang, J.; Webb, A. R.; Ameer, G. A. Tissue Eng. 2005, 1876-1885. 
56. Motlagh, D.; Yang, J.; Lui, K. Y.; Webb, A. R.; Ameer, G. A. Biomaterials 2006, 24, 
4315-4324. 
 
57. Yang, S.; Leong, K.; Du, Z.; Chua, C. Tissue Eng. 2002, 1-11. 
58. Liu, T. V.; Bhatia, S. N. Adv. Drug Delivery. Rev. 2004, 11, 1635-1647. 
59. Sales, V. L.; Engelmayr, G. C.; Johnson, J. A.; Gao, J.; Wang, Y.; Sacks, M. S.; 
Mayer, J. E. Circulation 2007, 116,55-63. 
 
60. Webb, A. R.; Kumar, V. A.; Ameer, G. A. J. Mater. Chem. 2007, 9, 900-906. 
61. Neeley, W. L.; Redenti, S.; Klassen, H.; Tao, S.; Desai, T.; Young, M. J.; Langer, R. 
Biomaterials 2008, 4, 418-426. 
 
62. Chen, Q.; Bismarck, A.; Hansen, U.; Junaid, S.; Tran, M. Q.; Harding, S. E.; Ali, N. 
N.; Boccaccini, A. R. Biomaterials 2008, 1, 47-57. 
63. Sundback, C. A.; Shyu, J. Y.; Wang, Y.; Faquin, W. C.; Langer, R. S.; Vacanti, J. P.; 
Hadlock, T. A. Biomaterials 2005, 27, 5454-5464. 
64. Gao, J.; Crapo, P. M.; Wang, Y. Tissue Eng. 2006, 917-925. 
65. Gao, J.; Ensley, A. E.; Nerem, R. M.; Wang, Y. J. Biomed. Mater. Res. Part A 2007, 
4, 1070-1075. 
66. Bettinger, C. J.; Orrick, B.; Misra, A.; Langer, R.; Borenstein, J. T. Biomaterials 
2006, 12, 2558-2565. 
67. Leclerc, E.; Furukawa, K. S.; Miyata, F.; Sakai, Y.; Ushida, T.; Fujii, T. Biomaterials 
2004, 19, 4683-4690. 
68. Weigle, T.; Schinkel, G.; Lendlein, A. Expert Rev. Med. Devices 2006, 3, 835-851. 
69. Pego, A. P.; Siebum, B.; Poot, A. A.; Grijpma, D. W.; Feijen, J. Tissue Eng. 2003, 9, 
981. 
70. Guan, J.; Fujimoto, K. L.; Sacks, M. S.; Wagner, W. R. Biomaterials 2005, 26, 3961-
3971. 
71. Sarkar, S.; Lee, G. Y.; Wong, J. Y.; Desai, T. A. Biomaterials 2006, 27, 4775-4782. 
72. Radisic, M.; Park, H.; Chen, F.; Salazer-Lazzaro, J.; Wang, Y.; Dennis, R.; Langer, 
R.; Freed, L.; Vunjak-Novakovic, G. Tissue Eng. 2006, 2077. 
  37 
73. Thakar, R. G.; Ho, F.; Huang, N. F.; Liepmann, D.; Li, S. Biochemical and 
Biophysical Research Communications 2003, 4, 883-890. 
74. Sarkar, S.; Dadhania, M.; Rourke, P.; Desai, T. A.; Wong, J. Y. Acta Biomaterialia 
2005, 1, 93-100. 
75. Mulder, M. M.; Hitchcock, R. W.; Tresco, P. A. J. . Biomater. Sci. – Polym. Ed. 
1998, 9, 731. 
76. Sodian, R.; Loebe, M.; Hetzer, R. ASAIO J. 2002, 48, 12-16. 
77. Sodian, R.; Sperling, J. S.; Vacanti, J. P. Tissue Eng. 2000, 6, 183. 
78. Lieshout, M. V.; Peters, G.; Rutten, M.; Baaijens, F. Tissue Eng. 2006, 12, 481. 
79. Wada, R.; Hyon, S.; Nakamura, T.; andIkada, Y. Pharm. Res. 1991, 1292-1296. 
80. Guan, J.; Stankus, J. J.; Wagner, W. R. J. Control. Release 2007, 1-2, 70-78. 
81. Dahiyat, B. I.; Posadas, E. M.; Iirosue, S.; Hostin, E.; Leong, K. W. Reactive 
Polymers 1995, 101-109. 
82. Malcolm, R. K.; McCullagh, S. D.; Woolfson, A. D.; Gorman, S. P.; Jones, D. S.; 
Cuddy, J. J. Control. Release 2004, 2, 313-320. 
83. Woolfson, A. D.; Malcolm, R. K.; Gallagher, R. J. J. Control. Release 2003, 3, 465-
476. 
84. Malcolm, K.; Woolfson, D.; Russell, J.; Tallon, P.; McAuley, L.; Craig, D. J. 
Control. Release 2003, 2, 217-225. 
85. Cussler, E. L. J. Control. Release 2003, 3, 399-320. 
86. Gu, F.; Neufeld, R.; Amsden, B. J. Control. Release 2007, 1, 80-89. 
87. Gu, F.; Younes, H. M.; El-Kadi, A. O. S.; Neufeld, R. J.; Amsden, B. G. J. Control. 
Release 2005, 3, 607-617. 
  
 
CHAPTER 2 
 
 
 
 
 
 
 
SYNTHESIS AND CHARACTERIZATION OF NEW 
PHOTOCURABLE AND BIODEGRADABLE 
ELASTOMERS 
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2.1 Introduction 
Biodegradable elastomers have attracted a great deal of interest in recent years 
due to their potential applications in the biomedical field as scaffolds for tissue 
engineering1-5or drug delivery carriers6-11. Biodegradable elastomers resemble soft tissues 
in that they can readily recover from relatively large deformations while maintaining their 
proper function without mechanical irritation to the surrounding tissues.12  
There are two classes of elastomers: thermoplastic elastomers13-15 and thermoset 
elastomers.5,12 Thermoplastic elastomers can be prepared from melt or solvent 
processings, and their elasticity comes from the phase separation of crystalline and 
amorphous regions. The two regions hydrolyze at different rates, and as such, the 
elastomers degrade heterogeneously resulting in a nonlinear loss of strength. Completely 
amorphous thermoset elastomer materials degrade more homogenously with a more 
linear degradation of physical properties.16-17 Because of these differences, our interest is 
in the preparation of amorphous thermoset elastomers, since it is desired that the 
scaffolds maintain their structural integrity before the newly formed tissue reaches its 
fully functioning capacity. 
There are two methods to prepare thermoset elastomers: thermal crosslinking and 
photocrosslinking. Thermal crosslinking conditions normally require high temperatures 
(90-130 ºC) and long fabrication times (24 h to several days).12,18-19 Photocrosslinking 
methods have several advantages which include 1) production of elastomers in several 
minutes at room temperature, allowing for the loading of thermosensitive drugs or 
proteins,20 2) fabrication of elastomers with better spatial and temporal control,21-23 3) the 
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tuning of mechanical properties and degradation by controlling the crosslinking density 
and the composition.  
To date, most of the photocured amorphous elastomers have been made from the 
copolymers of caprolactone with lactide and/or glycolide.17, 24-25 Star prepolymers26-27 (G 
= 0.59-5.3 MPa) and linear prepolymers28 (G = 1.66-12.3 MPa) have been synthesized 
from these starting materials. These elastomers, prepared using ring-opening 
polymerization, presented several challenges. For example, there was a limited number of 
cyclic monomers suitable for this method. In addition, the ratio of monomers in the 
copolymers had to be precisely controlled to ensure the prepolymers were amorphous.29 
Finally, polycaprolactone took months to years under physiological conditions to 
degrade. These polymers had 3-6% weight loss in phosphate buffered saline (PBS) after 4 
weeks degradation.27-28  
An alternative to ring-opening polymerization for the fabrication of biodegradable 
thermoset elastomers is polycondensation polymerization. By this method, a wide variety 
of monomers can be easily incorporated, allowing for the expansion of the elastomer 
properties. Langer recently reported the synthesis of a photocurable poly(glycerol-co-
sebacate) from polycondensation polymerization from multifunctional monomers.30 The 
Young’s modulus of the elastomers ranged from 0.05-1.38 MPa with degrees of 
acrylation ranging from 17-54%. A low degree of acrylation (17%) resulted in soft 
materials having high sol content (42%). This may be unfavorable for in situ 
polymerization as unreacted methacrylate functionalized macromers could diffuse into 
the surrounding tissues. In addition, the multifunctional approach suffers from the 
inability to vary properties by controlling the crosslinking chemistry. As such, it is more 
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desirable to have photocurable, biodegradable elastomers which can be prepared from 
polycondensation polymerization with high degrees of acrylation and better control of the 
polymer structures.  
Our lab has successfully synthesized a series of completely amorphous linear 
prepolymer liquids from hydromuconic acid and ethylene glycol oligomers.31,32 These 
amorphous prepolymers were prepared from facile polycondensation polymerization 
techniques, which can precisely control the composition of the resulting prepolymers and 
hence the network structure of the resulting elastomers. These elastomers were obtained 
by using thermal crosslinking conditions. Here, we expanded the scope of these materials 
to develop new linear amorphous prepolymers functionalized with photocurable groups. 
After UV irradiation, the fabricated elastomers present a wider mechanical property range 
and a faster degradation rate than the current available photocrosslinked amorphous 
elastomers. Because the prepolymers are liquid, they can be easily fabricated or molded 
into a wide array of devices and shapes.  
 
2.2 Experimental 
Materials. All chemicals were purchased from Sigma-Aldrich unless otherwise 
noted. 2,2-Diethoxyacetophenone (DEAP) was purchased from Acros. Poly(lactic-
glycolic acid) (PLGA) was purchased from Boehringer Ingelheim with relative molecular 
mass 15,000. Adipic acid (AA) was recrystallized from distilled water prior to use. 
Diethylene glycol (DEG) was dried overnight over calcium hydride and distilled.  
Preparation of hydroxyl endcapped poly(diethylene glycol adipate). A 50 mL 
round-bottom flask was charged with the calculated amount of adipic acid and diethylene 
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glycol. The contents of the flask were placed under a nitrogen atmosphere. The mixture 
was stirred at 130 ºC using magnetic stirring until a homogeneous melt was formed. 
Stannous 2-ethylhexanoate (1.0 mol %) was added to the melt. The mixture was stirred 
for 1 h, and the pressure was reduced to 20 mmHg. The reaction was allowed to proceed 
at 20 mmHg for 23 h, for a total reaction time of 24 h. Polymerization was terminated by 
precipitating the polymer into cold methanol (-78 ºC).  
Preparation of methacrylate endcapped poly(diethylene glycol adipate). A 25 
mL round-bottom flask was charged with 3 g of hydroxyl endcapped prepolymer. The 
flask was sealed, flame-dried, and purged with nitrogen. This procedure was repeated 3 
times. Under the flow of nitrogen and stirring, 15 mL of fleshly distilled methylene 
chloride and triethylamine (4.2 mole equiv) were injected into the flask. The flask was 
cooled to 0 ºC using an ice-water bath. Methacryloyl chloride (4.2 mole equiv) was added 
dropwise into the flask. The reaction proceeded overnight and was terminated by washing 
with 1 N hydrochloric acid twice, sodium bicarbonate solution (3%) twice, distilled water 
once and saturated sodium chloride solution once. The collected fraction was dried over 
magnesium sulfate. Magnesium sulfate was removed by filtration, and the solvent was 
removed under reduced pressure. The residue was precipitated in cold methanol (-78 ºC). 
Preparation of hydroxyl endcapped poly(tetraethylene glycol adipate) and 
preparation of methacrylate endcapped poly (tetraethylene glycol adipate). The 
procedures were the same as above. 
Elastomer fabrication. Elastomer films (50 mm x 15 mm x 0.5 mm) were 
prepared by spreading a mixture of the liquid prepolymer (0.25 g) and photoinitiator 
(DEAP) (0.1-5 wt %) on a glass mold. The mixture was put inside of a UV oven chamber 
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(ECL-500), purged with N2 for 10 min, and subjected to 30 mW/cm2 UV irradiation (365 
nm) for the prescribed time (1-10 min).     
Porous scaffold fabrication. To the mixture of methacrylated prepolymer and 
photoinitiator (DEAP), three weight equiv of sodium chloride (90-150 µm) was added. 
The mixture was then transferred to a 20 mm x 20 mm square mold and subjected to UV 
exposure as above. After the radiation, the mold was immersed in distilled water for 24 h 
and was peeled from the mold while in water. The distilled water was changed every 24 h 
for 4 days. After drying in a fume hood for several days, the photographs of the prepared 
scaffolds were taken.  
Bilayer scaffold fabrication. For the nonporous phase, a glass rod (~ 5 mm in 
diameter) was coated with mixture of prepolymer and photoinitiator. The rod was 
subjected to UV exposure for 2 min without N2 purge. After the irradiation, the glass rod 
was coated with the mixture of salt, prepolymer and photoinitiator.  The glass rod was put 
inside the UV oven again, purged with N2 for 10 min, and subjected to irradiation for 10 
min. The cured bilayer scaffold was slowly removed from the glass rod after immersion 
in distilled water for half an hour. The pores were produced after leaching away the salt 
in distilled water for 4 days with water changed every day. After drying in a fume hood 
for several days, the photographs of the prepared scaffolds were taken. The cross section 
image of the scaffold was taken by SEM. 
 
2.3 Characterization 
 1H NMR spectra were acquired in deuterated chloroform on a Bruker 400 
AVANCE.  A Waters Gel Permeation Chromatography (GPC) system was used to 
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measure polymer molecular weights relative to polystyrene standards.  The 
measurements were taken at 40 ºC with THF as the mobile phase in four columns.  
Fourier transform infrared spectroscopy (FTIR) spectra were acquired on a PerkinElmer 
Spectrum BX. Thermogravimetric analysis (TGA) was performed using a Perkin-Elmer 
thermogravimetric analyzer with a heating rate of 10 ºC/min in a N2 atmosphere. Glass 
transition temperatures and melting points were measured on a Seiko 220C differential 
scanning calorimeter (DSC) using the second heat at a heating rate of 10 ºC/min. Water-
in-air contact angles were measured at room temperature using a KSV instrument and 
imaging system using the sessile drop method. Four independent measurements at 
different sites were averaged. The contact angle was monitored with time from 0 to 5 
min. Scanning electron microscopy (SEM) was performed on a Hitachi S-4700 SEM. 
Sol content analysis was conducted by swelling a 0.15 g elastomer film in 
methylene chloride for 24 h at 25 ºC. The solvent was removed and the percent soluble 
fraction (Qs) was determined according to the following equation,  
Qs = 100 x (mi – mf) / mi 
where mi and mf represent the initial and final masses. Each measurement was performed 
on three separate samples. The value was reported as the average of the three 
measurements. 
 In vitro degradation studies and mechanical property measurements. Dumb 
bell shaped elastomer samples were immersed in 20 mL of phosphate buffered saline 
(PBS) (pH 7.4 and 37 ºC) in a 20 mL scintillation vial. At each sampling time point, the 
elastomers were removed, blotted dry, and measured. The slabs were then subjected to a 
tensile measurement while hydrated. The mechanical data were collected on an Instron 
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5566 at a crosshead speed of 10 mm/min at 25 ºC. The Young’s modulus (G) was 
calculated using the initial linear portion of the stress/strain curve (0-5% of strain). The 
pieces from the tensile measurement were collected and dried under mild heat in a 
vacuum oven for 24 h. The dried mass was then measured. All measurements were made 
in triplicate. 
In vitro biocompatibility. An NIH 3T3 fibroblast cell line was used. Glass Petri 
dishes (60 mm diameter) were soaked in ethanol overnight, wiped dry, etched with HF 
solution (5%) for 1 min, rinsed with distilled water and wiped dry. To the dish was added 
2 mL of methylene chloride solution of the prepolymer (1%) with 1 wt% of DEAP. The 
dishes were transferred into a UV chamber after evaporation of the solvent in air. The 
elastomer was formed after 10 min N2 purge and 2 min UV irradiation of the prepolymer 
mixture. The control used for this study was the dish covered by PLGA (1 wt% in 
CH2Cl2, solvent evaporated for 24 h in air and sterilization by UV radiation for 15 min). 
The dishes were rinsed with sterile water and PBS 3 times and incubated at 37 ºC for 2 h 
in cell growth medium (Eagle minimal essential medium (EMEM) + 10 v/v% fetal 
bovine serum (FBS) + penicillin (100 IU/mL) + streptomycin (100 µg/mL)) to remove 
any residuals. Each dish was seeded with fibroblast cells and 5 mL of growth medium. 
The cells were incubated at 37 ºC with 5% CO2. The morphology of attached cells was 
observed after 24 h incubation and recorded with an inverted microscope (Zeiss Axiovert 
200) equipped with a Dage 240 digital camera.   
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2.4 Results and discussion 
2.4.1 Synthesis and characterization of liquid prepolymer 
A series of polyesters made from the polycondensation polymerization of adipic 
acid and ethylene glycol dimers (DEG) or tetramers (TEG) are shown in Figure 2-1. By 
controlling the feed ratio of the two monomers, hydroxyl endcapped prepolymers with 
number average molecular weights from 1 x 103 g/mol to 7 x 103 g/mol were easily 
prepared. The methacrylate endcapped prepolymers were achieved by using methacryloyl 
chloride to react with the endcapped hydroxyl groups. The glass transition temperatures 
for the methacrylate functionalized prepolymers were near -50 oC, while the glass 
transition temperatures for photocured elastomers were -59 oC to -31 oC with the EG 
oligomer length and molecular weight not having a significant effect on the thermal 
properties (Table 2-1). 
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Figure 2-1. Synthesis of photocurable polyester dimethacrylate and elastomer formation  
 
Table 2-1. Characterization of the prepolymer liquids and prepared elastomers 
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Figure 2-2 shows the 1H NMR spectra of a representative hydroxyl endcapped 
prepolymer (A) and a methacrylate endcapped prepolymer (B) (DEG-4K), with all the 
peaks assigned.27 The methacrylation of the end termini of the prepolymer was confirmed 
by the spectrum. 1H NMR of the methacrylate group endcapped prepolymer (B) clearly 
showed peaks at δ = 5.52 and 6.1 ppm, corresponding to the vinyl protons of the 
methacrylate group, and δ = 1.9 ppm corresponding to the methyl protons of the 
methacrylate group. The removal of unreacted methacryloyl chloride in the final 
prepolymer was confirmed by the absence of peaks at δ = 6.59, 6.25 and 2.43 ppm 
corresponding to the vinyl and methyl protons of methacryloyl chloride.  The degree of 
methacrylation was consistent in most methacrylate endcapped prepolymers, and ranged 
from 80% to 90%, as calculated according to the literature from the integration ratio of 
peaks at M and N (Figure 2-2 (B)).26,33  Finally, methacrylation did not significantly alter 
the molecular weight or polydispersity of the prepolymers, which can be seen clearly by 
the GPC chromatograms of the hydroxyl endcapped prepolymer and methacrylate 
endcapped prepolymer in Figure 2-3.  
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Figure 2-2. A) 1H NMR spectra of a hydroxyl endcapped prepolymer, B) a methacrylate 
endcapped prepolymer 
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Figure 2-3. GPC chromatograms of A) a hydroxyl endcapped prepolymer and B) a 
methacrylate endcapped prepolymer (DEG-7K) 
 
 
 
 
 
 
 
 
 
 
Figure 2-4. FTIR spectra of A) a hydroxyl endcapped prepolymer and B) a methacrylate 
endcapped prepolymer (DEG-4K) 
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The FTIR spectra of hydroxyl endcapped prepolymer (A) and methacrylate 
endcapped prepolymer (B) are shown in Figure 2-4. The FTIR spectrum of (A) showed 
an absorption band at 3526 cm-1 due to the terminal hydroxyl group. This band almost 
disappeared in (B) due to methacrylation. The bands at 2952 cm-1 and 1133 cm-1 were 
attributed to the C-H stretch and ether stretch, respectively, and were present in both 
polymers. The peak at 1637 cm-1 in (B) was ascribed to the vinyl group signals due to the 
methacrylate functionality.29  
 
2.4.2 Characterization of photocured elastomers 
The methacrylate endcapped prepolymers were crosslinked using 365 nm UV 
radiation and 2,2-diethoxyacetophenone (DEAP) as the photoinitiator. The crosslinking 
conditions were optimized with regard to UV exposure time and photoinitiator 
concentration. The representative methacrylate endcapped prepolymer used here was 
DEG-2K. In one set of experiments, the photoinitiator concentration was kept at 1 wt% 
while UV radiation times were changed from 1 min to 10 min. The prepared elastomers 
were weighed, immersed into 20 mL of methylene chloride overnight at 25 oC, dried 
under vacuum and reweighed. The sol content was determined from the weight loss, and 
its relationship to exposure time is shown in Figure 2-5 (A).  After 1 min exposure, the 
sol content in all of the elastomers was consistently near 8%.  This indicated that 
photocuring is a fast process and that 1 min exposure is sufficient to fully cure the 
elastomers. Figure 2-5 (B) illustrates the effect of the photoinitiator concentration to the 
sol content, with the exposure time kept at 1 min. At 0.1 wt% photoinitiator, the sol 
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content of the elastomer was already minimized. Therefore, the optimized crosslinking 
conditions were 0.1 wt% photoinitiator and 1 min UV exposure time, suitable for the 
incorporation of sensitive drugs or proteins, such as vascular endothelial growth 
factor.9,10  
 
 
 
 
 
 
 
Figure 2-5. Sol content values versus A) exposure time and B) photoinitiator 
concentration 
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nontoxicity. In the following text, the mechanical, degradation, surface properties and 
biocompatibility of our elastomers are discussed.  
 
The mechanical properties of the fabricated elastomers were examined first. 
Dumb bell shaped samples were mounted for stress-strain test in triplicate. We studied 
the influences of different ethylene oxide oligomers and prepolymers of different 
molecular weight on the mechanical properties. Figure 2-6 (A) shows typical stress-strain 
0
10
20
30
40
50
60
70
80
90
100
So
l c
o
n
te
n
t (
%
)
UV time (min)
0 1 2 4 6 10
A 
0
10
20
30
40
50
60
70
80
90
100
So
l c
o
n
te
n
t (
%
)
Initiator Concentration (%)
0 0.1 0.5 1 2 5
B 
  54 
curves of the elastomers. As can be seen from Figure 2-6 (B), the mechanical properties 
of the DEG and TEG based elastomers followed similar trends as the prepolymer 
molecular weights increased. Elastomers made from prepolymers of lower molecular 
weight presented higher Young’s modulus and shorter extension. While prepolymers of 
higher molecular weight led to the elastomers with lower Young’s modulus and longer 
extension. Since the elastomers are a crosslinked network, the crosslinking density 
depends on the density of available photocurable groups (methacrylate groups). For 
prepolymers with lower molecular weights, the density of methacrylate groups is higher 
than the density of methacrylate groups in prepolymers of higher molecular weight. As 
such, prepolymers of lower molecular weight lead to stronger elastomers. Overall, 
Young’s modulus ranged from 0.12-10.3 MPa for elastomers made from prepolymers of 
molecular weights ranging from 1K to 7K. It is in the mechanical range for some soft 
tissues inside of the body, such as the knee articular cartilage (G = 2.1-11.8 MPa), and the 
cerebral vein (G = 6.85 MPa). There are only a few photocurable elastomers in the 
literature that show this wide mechanical property range.16,30 
 
 
 
 
 
 
Figure 2-6. A) Typical stress-strain curves of the elastomers, B) Young’s modulus of 
elastomers versus prepolymer molecular weight 
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
St
re
ss
 
(M
Pa
)
 TEG - 1K
 TEG - 2K
 TEG - 4K
 TEG - 7K
Strain (mm/ mm)
A 
0
2
4
6
8
10
12
MW of Prepolymer (g/mol)
Yo
u
n
g'
s 
M
o
du
lu
s 
(M
Pa
)
 TEG
 DEG
1K 2K 4K 7K
B 
  55 
Next, we studied the degradation properties of the photocured elastomers. In vitro 
mass loss of elastomers in PBS over 5 weeks was measured (Figure 2-7). Both sets of 
elastomers prepared from diethylene glycol and tetraethylene glycol with molecular 
weights ranging from 1K to 7 K were used. During week one, the elastomers degraded at 
a rather fast rate with the highest loss of approximately 10% of its original weight, seen 
for the TEG-7K sample. In the following weeks, the elastomers presented stable 
degrading profiles. At 5 weeks, the fastest degradation was seen in the DEG-7K sample 
with 16% of its original weight lost. Also, the degradation rate changed slightly with the 
molecular weights of the prepolymers. Elastomers fabricated from higher molecular 
weight prepolymers (such as 7K) degraded faster than the elastomers prepared from 
lower molecular weight prepolymers (such as 1K). This can be explained in the same 
manner as above. The former has less photocurable density in the elastomer, so the 
network is not as tight as the later. It is easy for water molecules to enter the network and 
increase the exposure of the elastomer with the medium. At the same time, it is also easy 
for the degraded products to diffuse out of the matrix.27  
  
 
 
 
 
 
Figure 2-7. Percentage of weight loss of DEG and TEG based elastomers with different 
molecular weights during in vitro degradation in PBS (pH 7.4) at 37 ºC  
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When a scaffold is used to support cell growth, it is expected that the scaffold will 
maintain sufficient strength before the formed tissues can fully function. Since the 
materials are degrading during the application, it is important to know the influence of 
degradation on the mechanical properties. Figure 2-8 shows the change of Young’s 
modulus as the degradation progressed in PBS. Elastomers made from DEG and TEG 
prepolymers with different molecular weights were investigated for 5 weeks. After each 
week, three samples from each group were taken out, blotted dry, and mounted for 
Instron tension testing. Both sets of elastomers showed similar trends for the change of 
Young’s modulus, decreasing as the degradation proceeded. When further examined, the 
percentage of Young’s modulus loss after 5 weeks of degradation versus the molecular 
weight of prepolymers showed an interesting trend (Figure 2-8 (C)), which can be 
explained by the balance of diffusion and auto-catalysis effects. For elastomers made 
from prepolymers of low molecular weight (such as 1K), the crosslinking density is high, 
making it difficult for water molecules to penetrate into the matrix and slowing 
degradation. At the same time, the degraded acidic by-products have difficulty diffusing 
out of the network, causing an auto-catalysis effect. In this case, the auto-catalysis is 
dominant, leading to an accelerated degradation and increased chain scission with 
significant Young’s modulus loss of 40%. For elastomers made from prepolymers of high 
molecular weight (7K), the crosslinking density is low and the network is loose. As such, 
water molecules can easily enter the network and the degradation products easily diffuse 
out of the network. The loss of Young’s modulus after 5 weeks immersion in PBS is 
similar to the elastomers made from 1K molecular weight prepolymers, also about 40%. 
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Here, the diffusion is clearly dominant. Elastomers made from prepolymers with a 
molecular weight of 2K allowed for limited exposure of the network to penetrating water 
molecules and for degraded acidic by-products to diffuse out of the network, cancelling 
the auto-catalysis effect. Balanced by these two main factors, the loss of Young’s 
modulus was the smallest seen at only 6% after 5 weeks of degradation. This is one of the 
first reports of this trend of Young’s modulus loss versus the molecular weights of 
prepolymers. 
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Figure 2-8. Changes of Young’s moduli of elastomers during in vitro degradation study 
in PBS (pH 7.4). A) TEG based elastomers with different molecular weights, B) DEG 
based elastomers with different molecular weights, C) Percentage of Young’s modulus 
loss after 5 weeks for all elastomers 
 
The hydrophilicity of the surface should be suitable for cells be able to attach to 
the scaffold surface and grow. As a first probe of the hydrophilicity, we studied the 
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surface properties of our elastomers using advancing water-in-air contact angle 
measurement. While the mechanical and degradation properties of elastomers made from 
diethylene glycol (DEG) and tetraethylene glycol (TEG) were similar, the surface 
properties of the two sets of elastomers differed significantly (Figure 2-9). The 
elastomers made from diethylene glycol were more hydrophobic (contact angle stabilized 
at ~ 50 θ after 5 min) than the elastomers made from tetraethylene glycol (contact angle 
stabilized at ~ 20 θ after 5 min). To be a good candidate for cell attachment, the optimal 
contact angle range for biomaterials is 30-60 θ23, placing our materials in a suitable 
contact angle range to support cell growth. 
 
 
 
 
 
 
 
 
 
 
Figure 2-9. Water-in-air contact angle profiles of elastomers of DEG and TEG after 5 
min      
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We also examined the cytotoxicity of our elastomers. The photocured elastomers 
appeared to be biocompatible in vitro. NIH 3T3 fibroblast cells were seeded 
homogeneously on elastomer-coated glass Petri dishes with the biocompatible PLGA-
coated dishes as controls. Before the experiment, the dishes were rinsed with sterile water 
and phosphate buffered saline and incubated for 2 h in cell growth medium to sterilize the 
surfaces and remove any residuals. The fibroblast cells were transferred to all dishes with 
the cell growth medium. Figure 2-10 shows the cell morphology on elastomer DEG - 4K 
and PLGA after 24 h culture. The fibroblast cells on the elastomer surface showed 
normal morphology comparable to PLGA, a commercially used biomaterial.  
 
 
 
 
 
 
 
 
Figure 2-10. NIH 3T3 fibroblast cells grown on DEG - 4K (left) and PLGA (right) after 
24 h culture 
Lastly, we tried to fabricate different scaffolds from our elastomers. Since our 
photocurable prepolymers are completely amorphous liquids, they can be easily 
fabricated into different structures. Figure 2-11 shows the components of the bilayer 
scaffold (TEG-7K) that was fabricated to mimic the small diameter blood vessel. 
DEG - 4K PLGA - 15K 
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Compared to materials in the literature7, which took about 1 week, high temperature (120 
ºC) and high vacuum (4 mmHg), we can prepare the scaffold at room temperature and 
pressure in 15 minutes. 
 At the same time, examples of a solid scaffold and a porous scaffold (TEG-7K) 
were fabricated (Figure 2-11 (B), (C)). Porous scaffolds are broadly used in tissue 
engineering since the interconnected pores can assure cell growth and the transport flow 
of nutrients and metabolic waste. Moreover, the porosity can be tuned to improve the 
mechanical match to the surrounding tissue without fundamental materials 
modification.34,35 As can be seen from the above examples, our photocurable elastomers 
can be easily designed to be nonporous, porous or biphasic structures without using high 
temperature and high pressure. 
 
 
 
 
 
 
 
 
 
 
Figure 2-11. Scaffolds fabricated from photocured elastomers. A) a bilayer scaffold, B) a 
solid scaffold, C) a porous scaffold 
A
B
C
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2.5 Conclusions 
New photocurable prepolymer liquids were successfully prepared from adipic 
acid and ethylene glycol oligomers by condensation polymerization. At room temperature 
and pressure, the liquids were easily fabricated into completely amorphous elastomers by 
using 0.1 wt% of photoinitiator and 1 min UV exposure. By tuning the molecular weights 
of the prepolymers or compositions, the mechanical properties, degradation rates and 
surface properties were easily controlled. Initial in vitro cell studies showed that the 
elastomers were not cytotoxic. These studies indicate that these photocured, 
biodegradable elastomers show great potential as a new class of biomaterials. The in vivo 
biocompatibility of these elastomers will be discussed in Chapter 3.  
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CHAPTER 3 
 
 
 
 
 
 
 
IN VIVO STUDY OF BIODEGRADABLE 
ELASTOMERS 
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3.1 Introduction 
Biodegradable elastomers have been explored extensively for applications in the 
bioengineering field, especially as scaffolds in tissue engineering.1-14 These materials are 
particularly suitable for situations where the biomaterial mechanical properties need to be 
similar or close to the target organs or tissues, with no irritation to the surrounding 
environment.4 
A number of biodegradable elastomers have been fabricated, and generally they 
belong to two categories:  thermoplastic elastomers and thermoset elastomers. 
Thermoplastic elastomers normally phase separate into amorphous and crystalline phases. 
Because these two phases have different solvent behaviors, the degradation in vitro or in 
vivo is heterogeneous with no shape integrity.7 Completely amorphous thermosets have 
better structural stability upon degradation.15 To fabricate scaffolds with long term shape 
unity, amorphous thermoset elastomers are more desirable.  
For biodegradable polymers to be used as scaffolds in tissue engineering, an 
essential requirement is the biocompatibility of the fabricated scaffolds and also of  the 
degraded by-products. After the in vitro biocompatibility evaluation, the in vivo 
evaluation is the most direct method to test the material performance. A widely used 
approach is to subcutaneously implant the fabricated scaffolds to the back or fermur of 
animals, such as rabbits1,2, rats3-10, mice11,12, sheep13 and pigs14.  
We recently synthesized new photocurable and biodegradable elastomers. All the 
in vitro studies focusing on the mechanical, degradation, cytotoxicity and surface 
properties, demonstrated that these elastomers are good candidates for tissue engineering 
scaffolds. Herein, we further investigated the in vivo performance of these elastomers by 
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subcutaneous implantation on the dorsal parts of rats. The degradation, mechanical, 
surface properties and inflammatory response are discussed. 
 
3.2 Experimental  
 
Photocurable prepolymer synthesis.  The synthesis of methacrylate 
prepolymers have been described in Chapter 2. Herein, poly(diethylene glycol-adipate) 
based elastomers were used for the entire experiment with poly(lactic-glycolic acid) 
(PLGA) as the control.  
 
Elastomer fabrication. The methods of preparation and characterization of the 
elastomers were as described previously in Chapter 2. Briefly, the calculated amounts of 
adipic acid and diethylene glycol were polymerized with stannous 2-ethylhexanoate 
catalyst at reduced pressure at 130 ºC for 24 h to get hydroxyl endcapped prepolymers. 
These hydroxyl groups then reacted with methacrylol chloride at room temperature 
overnight to prepare methacrylate endcapped prepolymers. The vinyl endcapped liquids 
(around 200 mg) were mechanically mixed with 1 wt% of photoinitiator (2,2-
diethoxyacetophenone) in a 2 cm x 2 cm square mold and subjected to UV exposure for 
10 min to fully cure. The cured films were evenly cut into 4 pieces, each with a size of 1 
cm x 1 cm.   
Control samples used in this experiment were square blocks made from PLGA, 
purchased from Boehringer Ingelheim with relative molecular mass 15,000 (50:50, 
carboxyl ended). PLGA solutions in CH2Cl2 (20 wt%) were cast into a PTFE mold. After 
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the evaporation of the solvent in air for 2 days, the formed blocks were carefully cut into 
square pieces (1 cm x 1 cm) and were dried in the fume hood for another 2 days.  
 
Subcutaneous implantation.  Elastomers made from diethylene glycol based 
prepolymers with ‹Mn› = 2 x 103, 4 x 103 and 6 x 103 g/mol were used (DEG-2K, DEG-
4K, DEG-6K). To sterilize the surfaces, 70% ethanol was used. The PLGA pieces were 
sterilized with ethylene oxide. DEGs and PLGA were implanted subcutaneously in 15 
nine-week-old female Sprague-Dawley rats (Charles River Laboratories, Wilmington, 
MA). During the surgery, rats were anesthetized using isoflurane and O2. While under a 
surgical plane of anesthesia (monitored for adequate anesthesia by monitoring 
wakefulness and response to handling and toe pinch), the rats were shaved off all hair on 
the dorsal portions of the right and left sides. The surgical areas were prepared with 
alternating applications of a 10% povidone-iodine solution and 70% ethanol. Four 1 cm 
longitudinal incisions were made to allow the implantation of 3 pieces of DEGs (each 
from elastomer prepared from prepolymer with ‹Mn› = 2 x 103, 4 x 103 and 6 x 103 g/mol) 
and 1 piece of PLGA. The incisions were closed using sterile 5-0 surgical suture, and an 
injection of 0.33% locaine was given at each injection site. The implantation sites were 
marked by tattoo marks 2 cm away from the implanted center. At each sampling point (1, 
2, 5, 6, 7 weeks), 3 rats were sacrificed, and tissue samples surrounding the implants were 
harvested with the intact implants, total of 12 samples. Two groups of polymer samples 
were retrieved for mechanical and surface studies, and one group was fixed with 10% 
formalin for 24 h. After extensive washing with distilled water, the samples were 
immersed in 70% ethanol and embedded in paraffin.  The slices were stained with 
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hematoxylin and eosin stain (H&E) and Masson’s Trichrome stain (MTS) for routine 
histological examination.   
 
Water uptake and degradation studies.  Immediately after explantation, all the 
elastomers were blotted dry, weighed and subjected to mechanical tests. After the tests, 
the pieces were collected and thoroughly dried in a vacuum oven. The water uptake was 
measured by the weight difference before and after drying:  
Qs = 100 x (mw – md) / md 
where mw and md  represent the wet mass and dry mass. 
The degradation rate was measured by weight difference after drying and the 
original weight before implantation: 
 Qs = 100 x (mi – mf) / mi 
where mi and mf represent the initial mass and final mass. 
 
Mechanical properties.  The mechanical properties of the explants were 
measured on an Instron 5566 at a crosshead speed of 10 mm/min at 25 ºC. The Young’s 
modulus (G) was calculated using the initial linear portion of the stress/strain curve (0-
5% of strain).  
 
Surface morphology.  First, photographs of both original samples and explants 
were taken by regular camera. Then, these materials were mounted on aluminum sample 
holders, and subjected to observation by atomic force microscopy (AFM). They were 
scanned in tapping mode with a Nanoscope III AFM (Digital Instruments, Inc., Santa 
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Barbara, CA) using silicon probes. Through Digital Instruments software, the images 
were processed with a second-order flattening routine. Roughness data were calculated 
by the contrast intensity on the images and 3-dimensional surface morphologies were 
produced. 
 
3.3 Results and Discussion 
 
3.3.1 Explant comparison 
 
 
Previously in Chapter 2, new completely colorless and amorphous elastomers 
were fabricated by UV exposure with Young’s modulus (G) ranging from 0.1-10 MPa 
and strain (ε) from 30-170%. These values are in the mechanical range for several soft 
tissues inside of the body, such as knee articular cartilage (G = 2.1-11.8 MPa), and 
cerebral vein (G = 6.85 MPa and ε = 83%). The degradation studies showed that these 
elastomers were fast degrading materials with weight loss up to 16% after 5 weeks 
incubation in PBS at 37 ºC. The water-in-air contact angle demonstrated that these 
elastomers were hydrophilic, and cytotoxicity studies indicated that these elastomers 
were nontoxic at the test conditions. All of these data implied that our elastomers could 
be good scaffold candidates for soft tissue replacement in tissue engineering.  
In this chapter, we further investigated the in vivo performance of these 
elastomers by subcutaneously implanting to the dorsal parts of 9-week old female rats. 
Poly(lactic-glycolic acid) (PLGA) was employed as the control to examine the 
biocompatibility of our elastomers, which is a FDA approved biomaterial, and has been 
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utilized broadly in tissue engineering2,5,9. However, this material is hydrophobic and 
crystalline, which makes it less favorable for cell attachment and spread.10  In this set of 
experiments, elastomers made from diethylene glycol based polyesters were used. The 
molecular weights for the prepolymers were ‹Mn› = 2 x 103, 4 x 103, and 6 x 103 g/mol 
(DEG-2K, DEG-4K, DEG-6K). Each week, samples were harvested from each rat. 
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Figure 3-1. Photographs of explants: PLGA (A,B,C) and elastomers (D, E, F, G, H, I). 
The elastomers shown here prepared from DEG-4K 
 
0 weekA 1 weekB 2 weeksC
0 weekD 1 weekE 2 weeksF
5 weeksG 6 weeksH 7 weeksJ I 
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Photographs were taken when these materials were explanted from rats every 
week, as shown in Figure 3-1. Samples made from PLGA (A, B, C), after one week 
implantation inside rats, lost their original shape, changing from transparent square 
blocks to opaque porous lumps with rounded edges. This trend continued at the second 
week. After 5 weeks of implantation, PLGA based materials totally deformed inside of 
the rat and disappeared from the incision sites.  
For DEG based elastomers (D, E, F, G, H, I), the structural stability was clearly 
evidenced by the photographs in Figure 3-1. Even after 7 weeks of  implantation inside 
rats, the samples maintained their original shapes without noticeable difference among 
the samples prepared from prepolymers of different molecular weights. These 
photographs shown here are elastomers made from prepolymer with ‹Mn› = 4 x 103 g/mol. 
The same structural properties were seen in all DEGs. These elastomers were lightly 
colored after implantation inside rats, but the integrity of the elastomers was consistent 
throughout the entire 7 week study.  
These results are comparable to the literature. Langer et al. fabricated  thermally 
crosslinked poly(glycerol sebacate) (PGS) as tissue engineering scaffolds for soft tissue 
replacement.10 It took 48 h at 120 ºC and 30 mTorr to fabricate the elastomer with 
Young's modulus of 0.282 MPa. PGS was implanted into rats with PLGA as the control, 
and similar phenomena were observed. PLGA distorted within 14 days and disappeared 
beyond 3 weeks. PGS maintained its integrity, but the surface roughened significantly as 
the experiment progressed. 
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3.3.2 Surface morphology 
 
Atomic force microscopy (AFM) was utilized to quantitatively study the surface 
morphology of explants, as well as the contoured features simulated by 3-D images 
(Figure 3-2). As can be seen from the images, there were cracks (about 0.5 µm) formed 
on the surface of the explants. As the experiments progressed, the cracks connected with 
each other and more small cracks (about 0.2 µm) formed in between. In addition, the 
roughness of the surface increased with time, which can be easily seen from the 3-D 
image simulations (Figure 3-2). The highest roughness could be observed by explants 
after 6 weeks, around 77 nm compared to roughness of the original surface around 1nm. 
At 7 weeks, the surface roughness decreased to 40 nm. This can be explained that the 
elastomers continued degradation inside of the rat with the roughest tips being worn away 
by the surrounding medium. The roughness data are summarized in Table 3-1. Root mean 
square roughness (RMS) and arithmetic roughness (Ra) were used to quantitatively 
describe the surfaces. Compared with PGS, which roughened significantly and was easily 
noticeable with cracks as large as 40 µm observed from SEM,10 our elastomers 
maintained a smoother surface with significantly smaller cracks (0.5 µm).  This result 
indicated that our elastomers had better shape maintaining capacity than PGS.  
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Figure 3-2. AFM images of elastomers at various time points of explantation with 
corresponding 3-D surface simulation (the images were processed with a second-order 
flattening routine), A) 0 week, B) 1week, C) 2 weeks, D) 5 weeks, E) 6 weeks, F) 7 
weeks  
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Table 3-1. Surface roughness of explants during the implantation study 
 
 
 
 
 
 
 
 
 
3.3.3 Water uptake and degradation rate 
 
To better understand the performance of the elastomers in vivo and to assess their 
potential as cell-supporting scaffolds, water uptake was investigated to determine the 
swelling of the implants. The degree of swelling of degradable polymers in vivo is a key 
parameter for proper implant materials. Excessive swelling is usually undesirable for an 
implant, as it distorts the shape of the implant and softens the polymer.10 Figure 3-3 
shows the percentage of water uptake versus the study time for DEG based elastomers. 
As can be seen, after 1 week implantation inside of the rats, three sets of elastomers 
showed different amounts of water uptake, with higher water uptake for elastomers made 
from prepolymers of higher molecular weight. For DEG-2K, water uptake was 5%; for 
DEG-4K, water uptake was 9%; for DEG-6K, water uptake was 16%.  After 2 weeks, the 
percentage of water uptake began to stabilize at 15% for DEG-4K and DEG-6K, and at 
Week RMS (Rq) (nm) Ra (nm) 
0 0.98 0.71 
1 23.45 18.33 
2 32.57 24.73 
5 60.01 48.01 
6 77.46 62.70 
7 39.36 29.99 
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10% for DEG-2K. It is interesting to see that for DEG-2K and DEG-4K based implants, 
the percentage of water uptake did not fluctuate significantly during the following 
studies. But for DEG-6K based elastomers, the percentage of water uptake increased 
consistently after 5 weeks of implantation with the highest water uptake of 27% after 7 
weeks of implantation. The water uptake of DEG-4K was close to the PGS implant, 
which had water content at 15% after 7 weeks of implantation.10 DEGs and PGS had less 
water uptake than PLGA did, which took up 67% water after only 2 weeks of 
implantation.  
 
 
 
 
 
 
 
Figure 3-3. Water uptake studies of DEG based elastomers prepared from prepolymers 
of different molecular weights 
The rate of mass loss is of fundamental importance in studying the degradation 
characteristics of a biodegradable polymer. The degradation rates of the elastomers were 
studied, and in vivo mass loss was faster than in PBS buffer at 37 ºC. As shown in Figure 
3-4, elastomers made from prepolymers of molecular weight 6K degraded fastest, 
followed by elastomers made from 4K and then 2K. After 7 weeks of implantation, DEG-
6K degraded 27%, DEG-4K degraded 16% and DEG-2K degraded 14%. For the PLGA 
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implant, the degradation was not significant at the first week. But it lost mass 
dramatically at the second week at 53%. After that time, PLGA could not be harvested 
from the implantation site. This phenomenon was observed previously in the literature.16 
While for the PGS implant, 70% of its original mass was lost after 7 weeks.10 These data 
indicated that our elastomers could maintain their designed structure longer inside body. 
The dependence of degradation rate in vivo on prepolymer molecular weight is similar to 
the in vitro degradation, where elastomers prepared from prepolymers of higher 
molecular weight degraded faster than the elastomers made from prepolymers of lower 
molecular weight. The difference for in vivo degradation and in vitro degradation is that 
the same elastomers tended to degrade faster in the physiological environment than in 
PBS solutions. Because the elastomers were subcutaneously implanted, the aqueous 
surroundings were significantly different from the in vitro experiments. There was not 
only hydrolyzed degradation happening, but enzymes were contributing to degradation as 
well. In this complex in vivo environment, we observed about twice faster degradation 
rate than in vitro experiments. 
 
 
 
 
 
 
Figure 3-4.  In vivo degradation of DEG based elastomers prepared from prepolymers of 
different molecular weights 
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3.3.4 Mechanical properties 
 
As the degradation progressed, the mechanical properties of explants changed 
(Figure 3-5). It is desired that the elastomers maintain sufficient mechanical strength 
while new tissue is formed.5 Elastomers of DEG-2K had an original Young’s modulus of 
G = 3.4 MPa, and it decreased to 1.14 MPa after 5 weeks of implantation. The percentage 
of Young’s modulus loss was 67%. For elastomers of DEG-4K, the percentage of 
Young’s modulus loss was 21%, decreasing from 0.9 MPa to 0.7 MPa. Elastomers of 
DEG-6K had the medium percentage of Young’s modulus loss, about 48% after 5 weeks. 
While for PGS implant, at day 35, the modulus is about 50% of the original.10 Once 
again, it indicated that our elastomers, especially DEG-4K, showed better sustained 
mechanical strength. The dependence of the percentage of Young’s modulus loss on 
prepolymer molecular weight after the in vivo study was not the same trend as we 
observed during the in vitro study, where DEG-2K had the smallest Young’s modulus 
loss of 6% after 5 weeks.  So the best way to evaluate the mechanical properties of a new 
biomaterial is to carry out in vivo study, while the in vitro study will give some clues 
about this material.  
Since the surface of the explants roughened gradually as the implantation 
progressed, accompanied with the Young’s modulus loss, it is hypothesized that the 
degradation mechanism for these sets of elastomers can be the combination of surface 
erosion and bulk degradation.17 The medium surrounding the materials diffused into the 
elastomer matrix and degradation happened inside of the bulk. Meanwhile, the elastomer 
surface degraded because of the extensive interaction with the media.  
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Figure 3-5. A) Young’s modulus of explants changed with the implantation time, B) 
Percentage of Young’s modulus loss after 5 weeks implantation versus the prepolymer 
molecular weight  
 
3.3.5 Cell response 
 
Figure 3-6 depicts the histological examination of cell response to the elastomeric 
specimens after 1 week of implantation. H&E (Figure 3-6 (A)) staining confirmed that 
there was loose connective tissue with minimal collagen fibers and evenly scattered 
plump spindle cells with oval nuclei (interpreted as fibroblasts). There were a few areas 
of minimal fibrin deposition on the inner surface of the rim. MTS (Figure 3-6 (B)) 
staining indicated that the formation of collagen after 1 week implantation. As the study 
progressed, it was difficult to collect good sections of specimens. It could result from the 
nature of the section preparation. Further study is needed to verify these results. But from 
the outside skin of the rats, we could not observe any difference from the elastomer side 
and the PLGA side.  
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Figure 3-6. A) H&E stained sample, B) MTS stained sample 
A
B
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3.4 Conclusions 
Photocured elastomers (DEGs) were studied in vivo with the commercial 
biomaterial PLGA by subcutaneous implantation to the dorsal parts of rats. PLGA lost 
structural integrity inside rats after 1 week of implantation. DEG implants preserved their 
implant geometry and showed good retention of mechanical strength. The implant 
surfaces were studied by AFM. These results indicated that the degradation of our 
elastomers could be the combination of bulk degradation and surface erosion. Our 
elastomers may prove useful in the biomedical field where the implant integrity is highly 
emphasized.  
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CHAPTER 4 
 
 
 
 
 
 
 
SYNTHESIS OF PHOTOCURABLE AND 
BIODEGRADABLE AMINE-CONTAINING 
ELASTOMERS AND INVESTIGATION OF THEIR 
APPLICATIONS AS DRUG CARRIERS 
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4.1 Introduction 
Biodegradable polymers with hydrolyzable chemical bonds have been extensively 
studied in the biomedical field, especially as drug release carriers. These labile chemical 
bonds include esters, anhydrides, ortho esters, acetals and related groups.1,2 Among them, 
polyester-based materials are one of the most widely investigated systems due to their 
availability and well-defined characterization.3 In this field, a controlled drug release 
system is more desirable.1 Recent work demonstrated that controlled drug delivery was 
possible with degradable elastomers due to their special osmotic pressure-driven 
release.4-6 
In addition, biodegradable polymers have been shown to respond to 
environmental stimuli such as pH change and enzymatic, offering many benefits as drug 
release systems.7-15 A significant amount of research has been done in this field and 
several new materials developed, such as poly(β-amino ester)s7-11, poly(hydroxyproline) 
esters1,12,  pullulan-histidine conjugates13, and branched polyesters14,15. Most approaches 
have primary amine, secondary amine and/or tertiary amine groups incorporated into the 
polymer backbone or side chain to endow pH sensitivity to the drug release system. The 
tunability of these amine groups allows the pH buffering capacity of the polymer to span 
a wide range according to the desired functionalites.11  
Besides ester groups, disulfides stand as another class of biodegradable groups. 
With the help of reducing agents, disulfides can be cleaved to the corresponding thiols.16 
Disulfide groups bring several advantages to the design of biodegradable polymers such 
as rapid cleavage by glutathione and thioredoxin reductases in the cytoplasm, which are 
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naturally present within cells at millimolar concentrations.17,18 Also, cytotoxicity can be 
decreased by avoiding the high charge density that is common in amine concentrated 
polymers. Disulfide-containing polyesters19, polyamines20-22, and polyamides23 have been 
developed and explored in applications as environmentally sensitive carriers. Besides the 
incorporation into the polymer backbone, disulfide-functionalized dimethacrylate 
crosslinkers have also been employed as bridges to connect two polymer chains.18, 24, 25 
Generally drug release systems are micro/nano sized polymeric particles, and are 
prepared by heterogeneous polymerization methods, either emulsion or inverse 
(mini)emulsion polymerization7, or by controlled radical26 or atom transfer radical 
polymerization (ATRP)18, 24, or by conjugate self organization13.  Herein, we utilized a 
newly developed technology, called PRINT (Particle Replication In Non-wetting 
Templates), which enables the fabrication of monodispersed particles with excellent 
control over size and shape, which plays an important role during the interaction of 
particles with the target cells.27Moreover, the fabrication process is highly reproducible, 
and the payload of drugs can be concisely controlled during the process. Finally, PRINT 
is compatible with a wide variety of raw materials.28  
Based on the advantages of PRINT technology and the promising properties of 
biodegradable elastomers, we synthesized a series of photocurable amine-containing 
polyesters. We chose to prepare elastomers fabricated from prepolymers made via 
polycondensation polymerization for several reasons: 1) a broad array of monomers 
available, 2) the ease of functionalization of the polymer backbone, and 3) the ease of 
synthetic control. As well, we chose a photocuring method to crosslink the network as it 
is significantly faster than thermal fabrication with better control over the entire structure 
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and shape of the final material. Using these photocurable liquids and a disulfide 
crosslinker, we fabricated monodispersed amine-disulfide containing particles via 
PRINT, and studied the cytotoxicity and intracellular uptake. Furthermore, we examined 
the possibility of these particles as environment sensitive drug carriers against the release 
of a hydrophobic drug (Doxorubicin) and a hydrophilic drug (Minocycline 
hydrochloride).  
 
4.2 Experimental 
 
Materials. All chemicals were purchased from Sigma-Aldrich unless otherwise 
noted. 2,2-Diethoxyacetophenone (DEAP) was purchased from Acros. Fluorocur™, the 
perfluoropolyether used as the molding material in the PRINT process, was purchased 
from Liquidia Technologies. Poly (ethylene glycol) monomethyl ether monomethacrylate 
(Mn=1000 g/mol) was purchased from Polysciences.  Adipic acid (AA) was recrystallized 
from distilled water prior to use. Diethylene glycol was dried over calcium hydride 
overnight and distilled. 1,4-bis (2-hydroxyethyl)piperazine (PIP) was recrystallized from 
ethanol prior to use. Poly(ethylene glycol) methacrylate (Mn= 526 g/mol) was dissolved 
in distilled water, and purified by extraction from diphenyl ether twice (collecting the 
aqueous layer), heptane twice, cyclohexane twice, and extraction from the cosolvent of 
dichloromethane/hexane (3:1) (v/v) (collecting the organic layer) twice to get rid of 
poly(ethylene glycol) dimethacrylate component and poly(ethylene glycol) component.29 
 
  89 
Preparation of hydroxyl endcapped poly(diethylene glycol-piperazine-
adipate). A 50 mL round-bottom flask was charged with calculated amounts of adipic 
acid, 1,4-bis (2-hydroxyethyl)piperazine and diethylene glycol. The contents of the flask 
were then placed under a nitrogen atmosphere. The mixture was stirred at 130 ºC using 
magnetic stirring until a homogeneous melt was formed. Stannous 2-ethylhexanoate (1.0 
mol %) was added to the melt. The mixture was stirred for 1 h, and the pressure was 
reduced to 20 mmHg. The reaction was allowed to proceed at 20 mmHg for 23 h for a 
total reaction time of 24 h. Polymerization was terminated by precipitating the polymer 
into cold methanol (-78 ºC).  
 
Preparation of methacrylate endcapped poly(diethylene glycol-piperazine-
adipate). A 25 mL two-neck round-bottom flask equipped with a condenser was charged 
with 3 g of hydroxyl endcapped prepolymer. The entire apparatus was sealed, flame-
dried, and purged with nitrogen. This procedure was repeated 3 times. Under the flow of 
nitrogen and stirring, 15 mL of fleshly distilled methylene chloride was injected into the 
flask followed by heating of the flask to 50 ºC using an oil bath. 2-Isocyanatoethyl 
methacrylate (4.2 mole equiv) was added dropwise into the flask with 2 drops of stannous 
2-ethylhexanoate. The reaction proceeded for 2 h under reflux, and was terminated by 
precipitation in cold methanol (-78 ºC) after removal of all solvent. 
  
Synthesis of the disulfide crosslinker: dithiopropionyl poly(ethylene glycol) 
dimethacrylate. Clean PEG-monomethacrylate (10 g) was dissolved in 60 mL dry 
CH2Cl2 with 3.9 g dicyclohexyl carbodiimide (DCC) and 0.5 g dimethylaminopyridine 
(DMAP).  3,3’-Dithiopropionic acid (2.3 g) in 30 mL dry THF was added dropwise to  
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the above mixture in an ice bath at 0 °C over 20 min. The resulting mixture was allowed 
to stir at room temperature overnight. The formed solids were removed by vacuum 
filtration, and the combined solvents were removed by rotary evaporation. The resulting 
oily residue was dissolved in CH2Cl2 (100 mL), and was washed with aqueous NaHCO3 
solution three times to remove excess diacid. After CH2Cl2 was removed, the resulting 
yellow oily residue was dissolved in THF (5 mL), and refrigerated at -5 °C for 12 h. The 
insoluble solids were removed by vacuum filtration, THF was removed by rotary 
evaporation, and the product dried in a vacuum oven at 35 °C for 12 h to form a yellow 
oily residue in 50 % yield.  
 
Preparation of drug loaded particles. Cylindrical particles with feature sizes of 
2 x 2 µm were fabricated by PRINT technology. First, a patterned Fluorocur™ mold was 
fabricated as the methods described elsewhere.28 Briefly, an 8 inch patterned silicon 
wafer (with feature sizes of 2 µm), which was set up inside an enclosed UV chamber, 
was covered with 20 mL of Fluorocur™ resin containing 0.1 wt% of 2,2-
diethoxyacetophenone. The system was then purged with nitrogen for 2 min and exposed 
to UV irradiation (λ=365 nm, power > 20 mW/cm2) for 1 min to cure the Fluorocur™ 
resin. The cured elastomeric mold was then gently peeled away from the surface. 
For a representative formula, the PRINT particles were derived from a mixture 
composed of 77 wt% methacrylate endcapped polyester liquid, 20 wt% PEG monomethyl 
ether monomethacrylate, 1 wt% 2,2-diethoxyacetophenone, and 2 wt% fluorescein.  
Drops of the mixture were randomly dispersed on the patterned elastomeric mold. A 
poly(ethylene) sheet (American Plastics Co.) was then placed over the mold, evenly 
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pressed by a roller and peeled off. The mold was covered by the same sheet again but in 
different directions, and the above procedures were repeated several times until a uniform 
coverage of the mixture on the patterned mold. Finally this poly(ethylene) sheet was 
peeled back at a rate of approximately 3.0 cm/min with heating. Following this, the mold 
was placed in the UV curing chamber. The chamber was purged with nitrogen for 2 min 
and UV irradiation was applied (λ=365 nm, power >20 mW/cm2) for 1 min. A physical 
means was used to harvest the particles.  A Drop of acetone (filtered through a 0.22 µm 
PTFE filter) was placed on the particle-filled mold, and this drop of acetone was gently 
moved along the surface of the mold using a glass slide. The collected acetone 
suspension was ultrasonicated for 10 min, and was centrifuged at 3200 rpm for 30 min 
using an IEC CENTRA CL2 Centrifuge (Thermo Electron Corporation). The supernatant 
was removed via aspiration, and the particle pellet was redispersed in 50 mL of fresh 
acetone by unltrasonication for 10 min followed by centrifugation for an additional 30 
min. This process was repeated 3 times and at the last time, the particle pellet was 
dispersed in a minimal amount of acetone and was transferred into an eppendorf tube and 
centrifuged in a microfuge (Fisher Scientific) for 20 min.  After removal of the 
supernatant, the tube was dried in a vacuum oven overnight. The weight changes for the 
eppendorf tube were recorded as the weight of the particles. 
 
Elastomer fabrication. Elastomer films (20 x 20 x 0.5 mm) were prepared by 
spreading a mixture of the liquid prepolymer (0.25 g) and 1 wt% photoinitiator (DEAP) 
on a glass mold. The mixture was put inside of the UV oven chamber (ECL-500), and 
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purged with N2 for 10 min, and then was subjected to UV irradiation (365 nm) for the 
prescribed time (2 - 10 min). 
 
4.3 Characterization 
 
 
1H NMR spectra were acquired in deuterated chloroform on a Bruker 400 
AVANCE.  A Waters Gel Permeation Chromatography (GPC) system was used to 
measure polymer molecular weights relative to polystyrene standards.  The 
measurements were taken at 40 ºC with THF as the mobile phase in four columns.  
Fourier transform infrared spectroscopy (FTIR) spectra were acquired on a Perkin-Elmer 
Spectrum BX. Thermogravimetric analysis (TGA) was performed using a Perkin-Elmer 
thermogravimetric analyzer with a heating rate of 10 ºC/min in a N2 atmosphere. Glass 
transition temperatures and melting points were measured on a Seiko 220C differential 
scanning calorimeter (DSC) using the second heat at a heating rate of 10 ºC/min. 
Scanning electron microscopy (SEM) was performed on a Hitachi S-4700 SEM. The 
mechanical data were collected on an Instron 5566 at a crosshead speed of 10 mm/min at 
25 ºC. The Young’s modulus (G) was calculated using the initial linear portion of the 
stress/strain curve (0-5% of strain). 
Surface charge analysis. The zeta potential of PRINT microparticles was 
measured using a ZetaPlus Zeta Potential Analyzer (Brookhaven Instruments 
Corporation). The microparticles were dispersed in distilled water at a concentration of 
0.3 mg/mL and the zeta potential was measured. 
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Sol content analysis. Sol content analysis was conducted by swelling a 0.15 g 
elastomer film in methylene chloride for 24 h at 25 ºC. The solvent was removed and the 
percent soluble fraction (Qs) was determined according to the following equation,  
Qs = 100 x (mi – mf) / mi 
where mi and mf represent the initial mass and final mass. Each measurement was 
performed on three separate samples. The value was reported as the average of the three 
measurements.   
pKa buffering study. pKa value of amine-containing polyesters was determined 
via a classical acid-base titration. The polyester liquid was dissolved in 0.1 M HCl with 
pH of 2. The solution was then titrated with 0.1 M NaOH solution in a stepwise manner 
in order to obtain the titration curves. The pKa value was calculated from the derivative 
of the curves.  
In vitro degradation studies. About 100 mg bulk elastomer samples were 
immersed in 20 mL of phosphate-buffered saline (PBS) (pH 7.4 and 37 ºC) in a 20 mL 
scintillation vial. At each sampling time point, the slabs were taken out, washed with 
distilled water and dried under mild heat in a vacuum oven for 24 h. The dried mass was 
then measured. All measurements were made in triplicate. 
Another set of particle degradation was proceeded by suspending 1 mg particles 
in 1 mL pH 5(FIXANAL, C6H8O7/NaOH) buffer and pH 7.4 buffer (phosphate buffered 
saline) (PBS) in eppendorf tubes, respectively. The tubes were incubated at 37 oC. 
Everyday, the tubes were shaken manually to get evenly dispersed solutions. A small 
drop of solution was taken out from each tube and sprayed on a glass slide for the optical 
microscopy study. 
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In Vitro drug release from particles. Freshly made pH 5 and pH 7.4 buffers 
were used. Particle suspensions (1.5 mL) (2 mg/mL) in different buffers were put into 
dialysis tubes (Fisher, Regenerated cellulose tubular membrane, MWCO 6,000-8,000). 
The bags were sealed and immersed into 20 mL of pH 5 and pH 7.4 buffers. The release 
medium was stirred at 250 rpm at 37 ºC. At the predetermined sampling time, 0.25 mL 
release mediums were taken out and the amount of DOX in the solution was determined 
via UV spectroscopy at 500 nm.  
Particle cellular uptake. Hela cells were used for cellular uptake. The day before 
the experiment, Hela cells were seeded at 2.0x104/100 µL SMEM (5% Fetal bovine 
serum + 5% Horse serum, 2 mM L-glutamine)/well in a 96-well plate (Costar 3595 
clear), and incubated overnight at 37 ºC. Next day Hela cells were about 95% confluence. 
The media was aspirated from cells, and washed once with Opti-MEM I/GlutaMAX I. A 
50 µL graded particle solution in Opti-MEM I/GlutaMAX I was added to each well. The 
wells were incubated at 37 ºC for 3 h. At the end of incubation, the medium was aspirated 
off, and washed once with DPBS. Cells were trypsinized with 50 µL/well of 1x Trypsin-
EDTA at 37 ºC for 5 min. Trypsin was neutralized with 150 µL of DMEM-10/well and 
cells were transferred to a 96 well round bottom plate.  The plates were centrifuged at 
1200 rpm for 5 min and the supernatants were poured off. Trypan blue (50 µL of 0.1%) 
was added, and left at room temperature for 10 min to quench fluorescence of particles on 
cell surfaces. Dulbecco’s Phosphate Buffers Saline (DPBS) (200 µL) was added and 
centrifuged at 1200 rpm for 5 min and the supernatants were removed. Cells were washed 
once with DPBS, resuspended in 200 µL DPBS and transferred into 1.1 mL microtubes 
for flow analysis (Cyan ADP analyzer, Dako Cytomation). All events were collected and 
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the percentage of cellular uptake represents the fluorescein positive cells against all cells 
collected.  
Cytotoxicity test.  Hela cells were used for cytotoxicity test. The procedures were 
similar to the beginning procedures of cellular uptake. The day before the experiment, 
Hela cells at 2.0 x 104/100 µL SMEM were seeded and incubated overnight at 37 ºC, and 
particles were added to each well. The wells were incubated at 37 ºC for 3 h. At the end 
of incubation, particles were replaced with 100 µL of fresh medium and 20 µL of cell 
proliferation assay reagent (Promega G3582) were added to each well.  The wells were 
incubated at 37 ºC for about 1 h to develop colors. The optical density at 492 nm was 
measured using a BioRad Model 3550 microplate reader (BioRad Laboratories). Cell 
viability was expressed as percentage of living cells against the cells in control which 
contained medium only.   
 
4.4 Results and discussion 
4.4.1 Synthesis and characterization of photocurable elastomers  
 
 
Amine-containing biodegradable polymers have been investigated extensively in 
gene delivery and drug release applications because of the cationic properties of the 
amine functional group, which can condense anionic DNA or load anionic drugs at 
physiological pH.17,30-32 The buffering capability from primary amine, secondary amine 
and tertiary amine groups can help to mediate the gene transfer effects as well as control 
drug release. Some of these cationic polymers bear the pendant amines in the polymer 
side chains and some contain tertiary amines in the polymer backbone, such as the 
  96 
poly(β-amino ester) library prepared from Michael addition of bifunctional amines to 
bisacrylamides.11,33  
Herein, we report a simple polycondensation polymerization method to synthesize 
new secondary and tertiary amine containing polyesters. The synthetic scheme is shown 
in Figure 4-1. The first step was to incorporate the tertiary amine into the polymer 
backbone by using 1,4-bis(2-hydroxyethyl)piperazine (PIP) as the donor. By controlling 
the feed ratio of PIP to diethylene glycol (DEG) and also the feed ratio of the two diols to 
adipic acid, hydroxyl endcapped polyester liquids with various number average 
molecular weights were easily prepared. Secondary amines were then added into the 
polymer backbone by using urethane chemistry. The strategy was to react the endcapped 
hydroxyl groups with 2-isocyanatoethyl methacrylate. The reaction was run at 50 oC for 
two hours. This process was monitored by FTIR spectroscopy.34   
 
 
Figure 4-1. Synthesis of methacrylate endcapped prepolymers 
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Two series of methacrylate endcapped prepolymers were synthesized. As shown 
in Tables 4-1 and 4-2. Table 4-1 includes samples (1-4) with different feed ratios of PIP: 
DEG prepared with a targeted prepolymer number average molecular weight near 5 x 103 
g/mol. The results of DSC analysis of the materials showed that when the feed ratio of 
PIP:DEG was less than 20:30, totally amorphous prepolymers were made. Table 4-2 is 
the summary of samples (3, 5, 6, 7) with prepolymer molecular weights ranging from 1 x 
103 g/mol to 6 x 103 g/mol at similar reaction conditions with the constant feed ratio of 
PIP:DEG = 20:30. DSC studies did not show any melting peaks, and the glass 
temperatures for all samples were near -30 ºC.  The sol content of the fabricated 
elastomers ranged from 7-15%, indicating high degrees of endcapping. 
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Table 4-1. Characterization of amine containing photocurable prepolymers at varying 
diol feed ratios 
Sample PIP:DEG  ratio 
feed observeda 
‹Mn› 
x 10-3 (g/mol)b 
PDIb Tgc Tmc Sol content 
(%)d 
 
1 40:10    40:11    4.3 1.6 -34 57 8.3 
2 30:20   30:22 5.2 1.7 -28 53 12.1 
3 20:30   20:26 6.2 1.5 -30 f 5.6 
4 10:40   10:38 6.5 1.5 -32 f 14 
 
 
 
 
 
Table 4-2. Characterization of amine containing photocurable prepolymers at a constant 
diol feed ratio 
Sample PIP:DEG  ratio 
feed observeda 
‹Mn› 
x 10-3 (g/mol)b 
PDIb Tgc Sol content 
(%)d 
 
3 20:30   20:26 6.2 1.5 -36 5.6 
5 20:30   20:27 1.1 1.9 -34 12.3 
6 20:30   20:27 2.1 1.7 -31 1.7 
7 20:30   20:28 3.3 1.6 -42 1.6 
 
 
a Determined by NMR; b determined by GPC; c determined by DSC, second heat, 10 ºC/min; 
 d extracted in methylene chloride for 24 h at 25 ºC; f materials were amorphous 
a Determined by NMR; b determined by GPC; c determined by DSC, second heat, 10 ºC/min; 
 d extracted in methylene chloride for 24 h at 25 ºC  
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Figure 4-2. 1H NMR spectra of A) hydroxyl endcapped prepolymer and B) methacrylate 
endcapped prepolymer 
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Figure 4-2 shows the 1H NMR spectra of a representative hydroxyl endcapped 
prepolymer (A) and a methacrylate endcapped prepolymer (B), with all the peaks 
assigned. The methacrylation of the end termini of the prepolymer was confirmed by the 
spectra. 1H NMR of the methacrylate endcapped prepolymer (B) clearly showed peaks at 
δ = 5.3, 5.6 ppm, corresponding to the vinyl protons of the methacrylate group, and δ = 
1.9 ppm corresponding to the methyl protons of the methacrylate group. The methylene 
groups (marked as i and j from spectrum (B)) from the 2-isocyanatoethyl methacrylate 
end group overlapped with the methylene groups from diethylene glycol. The degree of 
methacrylation (calculated by the same method from Chapter 2) was consistent in most 
methacrylate endcapped prepolymers, with the methacrylation conversion ranging from 
80% to 90%. The component ratio of piperazine versus diethylene glycol was found from 
the integration ratio of the peaks at 2.6 ppm and 4.2 ppm. These calculated ratios were 
close to the feed ratios of the two components. Finally, GPC studies showed that the 
endcapping of methacrylate groups onto the polyester prepolymer did not degrade the 
polymer backbone (shown in Appendix C).  
Amine groups have solution buffering capacity. Since amine groups were 
incorporated onto the prepolymer backbone, the solubility of the prepolymers differed in 
pH 5 and pH 7.4 buffers. In titration studies, the pKa value of Prepolymer 3 was found at 
6.2 (titration curve shown in Appendix C). Figure 4-3 depicts the solubility of 
Prepolymer 3 in pH 5 and pH 7.4 buffers. Instead of the clear solution seen in pH 5 
buffer, an opaque solution was observed for Prepolymer 3 in pH 7.4 buffer. This could 
result from the quaternization of the amine groups on the polymer backbone at pH 5 that 
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improved the solubility of this prepolymer. This pH sensitivity has been illustrated by 
other amine containing polymers.8 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-3. Polymer 3 in pH 5 and pH 7.4 buffers 
 
4.4.2 Mechanical properties, water uptake and degradation properties 
 
In the following discussion, the mechanical, degradation and water uptake 
properties will be the focus to study the potential of these biodegradable elastomers as 
drug release carriers.  
The mechanical properties of the fabricated elastomers were examined first. To 
possess osmotic pressure-driven release capacity, the materials have to be designed to be 
elastic. 2,2-Diethoxyacetophenone (DEAP) was used to photo initiate the amine 
containing polyester liquids. The photocuring conditions were consistent for all the 
fabricated elastomers: 1 wt% DEAP, 10 min exposure with N2 flow to ensure full 
network formation. Herein, we examined two elastomers made from Prepolymer 3 (‹Mn› 
= 6.2 x 103 g/mol) and Prepolymer 7 (‹Mn› = 3.3 x 103 g/mol). The dependence of 
mechanical properties and degradation properties on the prepolymer molecular weights 
pH=5 pH=7.4
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was explored. As can be seen from the stress-strain curves (Figure 4-4), both of the 
materials exhibited elastic properties, as indicated by the long extension up to 62%. 
Young’s modulus (G) was calculated from the data of 0-5% strain and ranged from G= 
2.4 MPa to G= 0.6 MPa for Elastomer 7 and Elastomer 3, respectively. These results 
were similar to our previous results from Chapter 2, where elastomers fabricated from 
low molecular weight prepolymers were tougher than the elastomers made from higher 
molecular weight prepolymers 
. 
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Figure 4-4. Tensile test of elastomers made from Prepolymer 3 (‹Mn› = 6.2 x 103 g/mol) 
and Prepolymer 7 (‹Mn› = 3.3 x 103 g/mol) 
Next, the kinetics of our elastomer degradation was also investigated using a pH 5 
buffer and a pH 7.4 buffer, since amine containing polyesters showed pH sensitive 
degradation and used for pH sensitive drug release.7,8 The degradation was monitored by 
the weight loss of elastomers over the time at 37 oC. Elastomers weighing 100 mg were 
used and the buffer solutions were change weekly. At each sampling point, the 
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elastomers were washed with distilled water and dried in a vacuum oven overnight at 40 
oC. The weight loss was taken as the difference of dried sample weight over the original 
sample weight. Figure 4-5 shows the degradation profiles of elastomers as a function of 
time. As the degradation progressed, all elastomers lost weight significantly. Elastomer 3 
degraded faster than Elastomer 7, indicating prepolymer molecular weight dependence 
consistent with previous results from Chapter 2. In general, the elastomers degraded 
faster at pH 7.4 than at pH 5. This result is consistent with the pH-degradation profiles of 
other amine-containing polyesters, including poly(4-hydroxy-L-proline ester), which 
contains mainly primary amine groups1,12, linear poly(β-amino ester)s, which contains 
tertiary amine groups 7, 8, 35, and hyperbranched poly(ester amine)s15, which contains 
primary, secondary and tertiary amine groups. It is hypothesized that the amine group on 
the polymer chain, either in the primary, secondary or tertiary status, acts as an 
intramolecular nucleophilic catalyst and contributes to the slow degradation at pH 5. At 
pH 7.4 a higher fraction of unprotonated amino groups in the polymer catalyze the 
hydrolysis of the ester groups in the polymer. It was noticed that for elastomers at pH 7.4 
buffer, the degradation profiles were rather linear after initial burst degradation. While for 
elastomers at pH 5 buffer, the degradation was slower after the initial burst degradation, 
and after 4 weeks, the degradation increased.  These fast initial and slow following 
phenomena were similar to the reported research by Lim’s group1,12, who observed a 
slower degradation rate after initial rapid degradation, which was contributed the 
different buffering capacity of the primary amine groups with the secondary and tertiary 
amine groups. In all, the degradation of these cationic elastomers was fast, with the 
fastest one losing 83% of its original weight after 5 weeks in pH 7.4 buffer. Similar 
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elastomers without the cationic compositions lost 15% of original weight after 5 weeks in 
PBS (from Chapter 2).  The degradation rates of the fabricated elastomers depend not 
only on the prepolymer molecular weight, but also the pH value of the medium. 
 
 
 
 
 
 
 
Figure 4-5. Degradation study of elastomers made from Prepolymer 3 (‹Mn› = 6.2 x 103 
g/mol) and Prepolymer 7 (‹Mn› = 3.3 x 103 g/mol) 
Along with the degradation studies, water uptake was also examined. It is an 
important parameter to indicate the interaction of the elastomer network with the 
medium. The common strategy used for water uptake is to compare the weights of 
hydrated samples with the weights of original samples. But for our experiment, the 
elastomers degraded rapidly, and it was more reasonable to compare the weights of 
hydrated samples with the weight of dried samples after hydration, as has been previously 
described for rapidly degrading materials.14 The water uptake measurement ran for 3 
days, and at the same time the degradation was monitored. Herein, we compared two sets 
of elastomers, one set made from DEG based prepolymers with ‹Mn›= 6 x 103 g/mol and 
the other set made from tetraethylene glycol (TEG) based prepolymers. These studies 
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were carried out at pH 5 and pH 7.4 buffers. It is clearly seen from Figure 4-6, TEG 
based elastomers showed a higher degree of water uptake and faster degradation rates to 
their DEG counterparts. It is not surprising to see this phenomenon since tetraethylene 
glycol is more hydrophilic than diethylene glycol, and this trend has been reported for 
different TEG and DEG containing polyesters previously.36 The water uptake and 
degradation for the same materials in different pH buffers were also compared. DEG 
based materials took up more water at pH 5 buffer than pH 7.4 buffer, but the degradation 
was faster in pH 7.4 buffer than in pH 5 buffer. The same trend could be seen by TEG 
based elastomers. It is likely that when the elastomers were immersed in pH 5 buffer, 
they were protonated, making it easier for water to penetrate into the network. The 
difference in degradation rates can be explained by the same phenomenon. At pH 7.4, a 
higher fraction of unprotonated amino groups in the polymer catalyze the hydrolysis of 
the ester groups in the polymer backbone. In all, the interaction of the elastomers with 
buffer is a complicated process, multiple factors can contribute and intertwine, and it is 
important to carefully to determine which one is dominant and significant. 
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Figure 4-6. Water uptake and degradation studies for DEG and TEG based elastomers; 3 
day study, ‹Mn›= 6 x 103 g/mol for all prepolymers 
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4.4.3 PRINT particle fabrication and properties 
 
 
Based on the understanding of these cationic elastomers, we were interested in 
exploring their applications as drug release carriers. There are numerous reported 
approaches to prepare micro- to nano- sized polymeric particles by emulsion7, self 
organization13, ATRP18, etc. Herein, we chose a novel imprint lithographic technique, 
PRINT (Particle Replication In Non-wetting Templates), to take advantage of its capacity 
to produce monodispersed particles in a wide range of shapes and sizes, two factors  
reported to significantly affect the interaction of particles and their targets.28 PRINT is 
also easy to utilize with excellent reproducibility. 
We fabricated 2 micron and 200 nm sized cylindrical particles using the following 
formulation: 77 wt% methacrylate endcapped prepolymers, 20 wt% PEG monomethyl 
ether monomethacrylate (known to increase the circulation of particles inside body),33 1 
wt% 2,2-diethoxyacetophenone, and 2 wt% fluorecein o-acrylate (for fluorescent effect). 
These monodispersed particles were fabricated by the method as described previously.28 
Figure 4-7(A) shows the fluorescent image of particles with 2 wt% of fluorecein o-
acrylate incorporation, which can be used for particle tracking. Figure 4-7(B) depicts the 
optical image of particles without fluorecein, and Figure 4-7(C) shows the SEM image of 
particle size of 200 nm. As can be seen from these images, monodispersed particles with 
different size and formulation can be easily fabricated by PRINT technology. These 
particles maintained their individual stable sizes and shapes after several hours in water, 
with no observed aggregation.  
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Figure 4-7. A) Fluorescent image of 2 µm particles. B) Optical image of 2 µm particles. 
C) SEM image of 200 nm particles  
 
4.4.3.1 PRINT surface charge  
 
Charged surfaces help to decrease the aggregation of particles and improve the 
interaction of particles with cells.27,28 The surface charge of the elastomeric particles (2 
micron) was studied by dispersing the particles in water at a concentration of 0.3 mg/mL 
and measuring the zeta potential. The zeta potential of the fabricated particles was -26 
mV ± 0.54 mV, in the range for stable particles. Generally for amine containing particles, 
the surface charge is normally positive in distilled water and near + 15 ~ +20 mV 
depending on the polymer compositions.35 The reason for the negatively charged particles 
can be traced back to the particle compositions. We incorporated 20 wt% of 
poly(ethylene glycol) (PEG) monomethyl ether monomethacrylate into the particle since 
PEG chains are well known for particle stabilization and extended circulation time.9 
Since the zeta potential for particles purely fabricated from PEG based polymers is 
around -35 ~ -40 mV in distilled water by our experiment, we believe that the PEG 
A
10 µm
B
10 µm
C
500 nm
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composition formed a hydrophilic sheath around the particles and the surface charge is a 
result of the combined effects from the amine functional group and the poly(ethylene 
glycol) chains. 
 
4.4.3.2 PRINT morphology in media 
 
To study the influence of degradation on the particle size and shape, we further 
examined the particle morphology as immersed in pH 5 and pH 7.4 buffers over a period 
of 8 days. Particles (1 mg/mL) were suspended in the buffers, and each day, a drop of 
evenly dispersed solution was removed and sprayed on a glass slide. The size and shape 
of the particles were examined using an optical microscope (Figure 4-8). As can be seen 
by these images, the particles could maintain their original shape and size after 8 days of 
incubation in different buffers. This indicated that the degradation progressed via bulk 
erosion.37 
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Figure  4-8. Microscopy images of particles in media for 8 days  
 
4.4.3.3  Cytotoxicity of PRINT particles 
 
 We further studied the cytotoxicity of the fabricated particles using Hela cells. 
Particles (2 micron) in culture medium were incubated with HeLa cells (4.0 x 104) under 
different particle concentrations for 3 h, while the culture dish with only HeLa cells and 
medium was used as a control. At the end of the incubation, cell proliferation assay 
reagent was added to develop the colors. The viability was expressed as the ratio of the 
number of living cells to the original number of cells. Figure 4-9 shows high viability of 
the cells in the presence of high concentrations of microparticles, indicating the non toxic 
nature of the fabricated particles.  
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Figure 4-9. Cytotoxicity evaluation of the elastomeric particles. Percentage of Hela cell 
viability versus particle concentration 
 
4.4.3.4  Cellular uptake of PRINT particles 
 
When used drug release carriers, it is desired that particles can penetrate and 
release the drug inside cells, rather than only cell surface adhesion. We carried out the 
quantitative cellular uptake study by incubating a fixed population of the cells with 
graded concentration of particles. We wanted to explore the role of dose-dependency on 
the particle concentration.  Hela cells were used for cellular uptake. Particles in different 
concentrations were added to Hela cell culture wells. The percentage of cellular uptake 
represents the fluorescein positive cells against all cells collected (Figure 4-10). For the 2 
micron sized elastomeric particles, approximately 90% of the particles had been taken up 
by the cells at the concentration of 220 µg/mL, which was comparable to positively 
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charged particles of similar size27 and indicated that the particles could be used as a 
potential drug release carrier.  
 
 
 
 
 
 
Figure 4-10. Cellular uptake of 2 micron sized particles by Hela cells in 3 h  
 
4.4.4 Drug release study 
 
In the following discussion, we studied first the applications of these elastomeric 
particles as drug release carriers for a hydrophobic drug model (Doxorubicin). 
Doxorubicin is a widely used hydrophobic anticancer agent, and numerous researchers 
are working in this field to develop its pH controlled release or protein sensitive 
release13,18. We are more interested in the pH adjusted drug release based on our 
elastomer structures. Furthermore, we incorporated a disulfide crosslinker to the drug 
release system and studied its adjustment to the Doxorubicin release. Lastly, we explored 
the amine-disulfide containing particles as a hydrophilic drug release carrier. 
Minocycline hydrochloride (MCH) was selected as a hydrophilic drug model. MCH, a 
member of the tetracycline antibiotic family, is useful in the treatment of a host of topical 
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bacterial infections. The tetracyclines are known to be moisture sensitive and unstable 
under conditions of low or high pH, heat and high humidity. Thus, a non-aqueous matrix 
was proposed to be a more appropriate vehicle for MCH because the absence of moisture 
in the matrix would prevent MCH degradation.38 Our particles can be a good MCH 
release matrix given the nature of our fabrication method.  
4.4.4.1 Doxorubicin release from the amine containing particles 
 
First of all, Doxorubicin containing particles (2 micron) were fabricated using the 
following formulation: 77 wt% methacrylate endcapped prepolymers (Prepolymer 3), 20 
wt% PEG monomethyl ether monomethacrylate, 1 wt% 2,2-diethoxyacetophenone, and 2 
wt% Doxorubicin (DOX). Since we fabricated the particles with the drug homogeneously 
dispersed inside of the precursor, the loading efficiency is the same as the feed amount, 
which is an advantage over the current loading techniques in which the loading efficiency 
depends on the ratio of the DOX and the mixture.18 After we fabricated the particles, we 
suspended them in pH 5 buffer and pH 7.4 buffer with the concentration of 2 mg/mL 
(particles/buffer) for 0.5 h. Then the suspensions were put into the dialysis tube and 
immersed in 20 mL buffer solutions. During each sampling point, 0.5 mL solution was 
taken out and UV-vis spectrometry was used to study the released DOX.  Figure 4-11 
shows the drug release profile of DOX in different buffer solutions, expressed as the 
percentage of accumulated amounts of DOX in the solution versus the study time. In the 
first 24 h, the drug released in both buffer solutions is similar, fast initial burst release 
followed by a slower release. After 24 h, the release differed for both solutions. For 
particles immersed in pH 5 buffer, the release amount was constant at 30% for the 
following 40 hours, and the release accelerated after 92 h to 45%. For particles immersed 
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in pH 7.4 buffer, the drug was almost linearly released after 24 h incubation in the 
medium to 76% after 92 h. The study of water uptake and degradation for the elastomers 
suggest that the DOX release is a degradation controlled process under these conditions. 
In pH 5 buffer, the polymer chains showed strong intramolecular interactions and the 
drug did not leach out very quickly. But for particles in pH 7.4 buffer, the particles began 
to degrade faster than in pH 5 buffer, and we can observe more DOX released in this 
system.  
 
 
 
 
 
 
 
 
Figure 4-11. Percentage of Doxorubicin released in pH 5 and pH 7.4 buffers versus time  
4.4.4.2 Doxorubicin release from amine-disulfide containing particles 
 
One of the advantages of PRINT is that different raw materials can be easily 
incorporated into the particle matrix.  We incorporated a disulfide crosslinker into our 
elastomeric particle matrix and the DOX release trend in pH 5 and pH 7.4 buffers 
switched. The synthesis of the disulfide crosslinker is shown in Figure 4-12. It is a yellow 
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liquid, and compatible with our photo fabrication process. 1H NMR spectrum (in 
Appendix C) was consistent with the published results.24  
 
 
 
 
 
 
Figure 4-12. Synthesis of disulfide containing dimethacrylate  
Doxorubincin loading particles were fabricated from the following formulation: 
50 wt% methacrylate endcapped prepolymers (Prepolymer 3), 20 wt% PEG monomethyl 
ether monomethacrylate, 20 wt% PEG disulfide dimethacrylate, 9 wt% Doxorubicin and 
1 wt% 2,2-diethoxyacetophenone. The drug release experiments were the same as above.  
As can be seen from the profiles (Figure 4-13), the incorporation of disulfide crosslinker 
changed the release trend of DOX in two buffers. Herein, DOX released faster in pH 5 
buffer than in pH 7.4 buffer, which can be explained as the elastomers degraded faster in 
pH 5 than in pH 7.4 buffers (the data in Appendix C). The accumulative release for DOX 
in pH 5 buffer was 50% after 10 h release study, and 24% at pH 7.4 buffer after 6 h. It 
was surprising to notice that the absorbance of DOX decreased as the experiment 
progressed after 4 h in pH 7.4 buffer and 8 h in pH 5 buffer.  We observed the decreasing 
amount of DOX in the release medium in the profiles. The reason for this phenomena is 
not sure, and it could result from the interaction of the disulfide groups with the released 
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drug since this phenomena did not show up in the previous experiments, where only the 
disulfide crosslinker was omitted. 
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Figure 4-13. Percentage of Doxorubicin released in pH 5 and pH 7.4 buffers versus time 
4.4.4.3 Minocycline hydrochloride release from amine-disulfide containing 
particles 
Minocycline hydrochloride (MCH) was chosen as the hydrophilic drug model, 
and our particles showed promising result as this drug release vehicle. The formulation 
was as follows: 50 wt% methacrylate endcapped prepolymers (Prepolymer 3), 20 wt% 
PEG monomethyl ether monomethacrylate, 20 wt% PEG disulfide dimethacrylate, 9 wt% 
MCH and 1 wt% 2,2-diethoxyacetophenone. The fabrication method was the same and 
the procedures for the drug release study were the similar as above. The only difference is 
that 2.5 mg/mL Glutathione reduced ethyl ester was used along with the pH 5 and pH 7.4 
buffer solutions.  Glutathione is a tripeptide found within cells at millimolar 
concentrations. It is used as a reducing agent to degrade disulfide-containing polymers 
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and does not exhibit significant cytotoxicity at the concentration of 10 mM.18 The in vitro 
release study was carried out at 37 oC with stirring. For each sampling point, we removed 
250 µL release medium and measured the drug amounts by HPLC with acetonitrile/water 
as the eluents at 350 nm. The release profiles can be seen by Figure 4-14, where the 
percentage of MCH release was shown versus the release time for a total run of 45 h.  
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Figure 4-14. Minocycline hydrochloride (MCH) release study in different media at 37 oC  
There were three trends indicated from the release profiles. First, the drug release 
in glutathione solution was not gradually increasing. After a burst release in the first hour, 
the release profile stabilized for around 10 h and then slightly decreased. By careful 
examination of HPLC profiles for the three systems, we observed the degradation 
components from the HPLC curves, which was not visible in the first several hours, and 
the amount was increasing as the study progressed. Moreover, we did not observe these 
peaks in the other two buffer systems. It is hypothesized that the reducing agent, 
glutathione, degraded the released minocycline hydrochloride. The total release after 45 h 
is around 16%. Second, the release in pH 7.4 buffer did not show burst release in the first 
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several hours, and the release was gradually increasing. After the 45 h study, the 
percentage of drug release is about 16%, which indicated that our disulfide-amine 
elastomeric particles could be a good system for controlled release of this type of drug. 
Third, the release of MCH in pH 5 buffer significantly differed from the others. During 
the first 3 h, the released amount of MCH was close to the MCH released amount in the 
glutathione solution. There was about 20% drug released in the medium. After that, the 
releases rate jumped up and then stabilized near 59%. The release trend of MCH in pH 5 
and pH 7.4 buffers was slightly different from DOX release in these two buffers. The 
reason for the difference is still under study, and it is possibly from the nature of the two 
drugs (DOX is hydrophobic and MCH is more hydrophilic). It has been reported that the 
disulfide-based polyamide degraded faster in pH 5 buffer than it did in pH 7 and pH 9 
buffers.23 
 
4.5 Conclusions 
 
In this chapter, we described the synthesis of novel amine containing 
photocurable polyesters. By controlling the feed ratio of the monomers, we can fabricate 
amorphous elastomers with variable molecular weight. By using the new developed 
PRINT technology, we fabricated monodispersed particles from this material. The 
cytotoxicity study indicated the fabricated particles are nontoxic to Hela cells and the 
cellular uptake study showed that a high percentage of particles can penetrate into Hela 
cells even at rather high concentration. Based on this information, we fabricated particles 
loaded with Doxorubicin (as a hydrophobic drug model) and Minocycline hydrochloride 
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(as a hydrophilic drug model) and studied the drug release in pH 5 and pH 7.4 buffers. 
The difference in the release behavior may come from the nature of the two drugs and/or 
from the composition of the particle formulation.  
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This dissertation focused on the use of a photo curable method to prepare 
biodegradable soft materials which have improved properties over the current available 
biomaterials. Specifically, polycondensation polymerization techniques were utilized to 
prepare prepolymer liquids.  
Chapter 2 served as the foundation for the rest of the work described in this 
dissertation. This chapter described the development of polymerization conditions and a 
full understanding of the properties of the resulting materials. By controlling the feed 
ratio of adipic acid and diethylene glycol or tetraethylene glycol, a series of hydroxyl 
endcapped polyester liquids with number average molecular weight ranging from 1x103 
g/mol to 7x103 g/mol were prepared. With the help of triethylamine, the hydroxyl 
endcapped liquids reacted with methacrylol chloride to afford methacrylate group 
endcapped polyester liquids, which can be easily photocured in 2 min with only 0.1 wt% 
photoinitiator. At these conditions, we can fabricate completely colorless and amorphous 
elastomers with Young’s modulus (G) ranged from 0.1-10 MPa and strain (ε) from 30-
170%, which is in the mechanical range for some soft tissues inside of the body, such as 
knee articular cartilage (G = 2.1-11.8 MPa)  and cerebral vein (G = 6.85 MPa and ε = 83 
%). The degradation studies showed that these elastomers were rapidly degrading 
materials with weight loss up to 16% after 5 weeks of incubation in PBS at 37 ºC, which 
is one of the fastest degrading materials fabricated under similar conditions. The water-
in-air contact angle results demonstrated that these elastomers were hydrophilic, and 
cytotoxicity studies indicated that these elastomers were nontoxic at the test conditions. 
All of these data implied that our elastomers could be good candidates as scaffolds for 
soft tissue replacement in tissue engineering.  
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Chapter 3 was the further study of the elastomers performance in vivo. We chose 
to subcutaneously implant these elastomers on the dorsal parts of rats. Similar approaches 
have been widely used in literature with the commercial biomaterial PLGA used as the 
control. Compared with the commercial biomaterial, which totally deformed after 3 
weeks of the in vivo study, our materials could maintain their structural integrity 
throughout the experiment. This result meant that our materials were promising as the 
scaffolds in tissue engineering, since it is desired that the scaffolds be able to maintain 
their structure for a period of time until the newly formed tissue can function well. The 
weight loss results showed that the elastomers followed the same dependence on the 
prepolymer molecular weight as the in vitro degradation study, but with faster 
degradation rates, and the highest weight loss of 26% after 7 weeks of implantation. 
Although the mechanical properties decreased as the degradation progressed, our 
materials remained in the mechanical range of several soft tissues. 
Since the photocurable method is easier to operate and faster than the thermal 
curing method, we fabricated bilayer scaffolds to mimic a small diameter blood vessel to 
take advantage of the mechanical properties, biocompatibility and fabrication method of 
our materials. The future direction for this project can be carried on to study the 
mechanical properties of this bilayer scaffold and tune the thickness of layers, pore size 
and distribution. As well, the nutrition flow, burst pressure and cell seeding on the 
scaffolds can be further explored. 
Better than seeding cells on the scaffolds, there are numerous researches on 
growth factor eluting scaffolds. The photocurable method should be good at maintaining 
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the bioactivity of the growth factors. And also, porous and nonporous scaffolds in 
different shapes can be easily fabricated from the salt-leaching method.  
Since the amine containing elastomers can be easily changed into cationic 
materials (in Chapter 4), it is possible to combine the neutral and cationic materials 
together to design some patterned surface to tune cell responsiveness and growth, which 
can be useful as micropatterned scaffolds.  
Chapter 4 utilized the versatility of step growth polymerization to expand the 
functionality of the photocurable elastomers by incorporation of amine containing 
monomers into the polymer backbone. By controlling the amount of the two diols, we can 
prepare completely amorphous polyester liquids with ‹Mn› from 1x103 g/mol to 6x103 
g/mol. As well, after endcapping with methacrylate groups, these liquids can be 
photocured at room conditions. We further studied the potential of these amine 
containing elastomers as drug release carriers. Instead of using the common drug loading 
particle methods, we fabricated monodispersed 2 micron sized particles from PRINT 
technology which have better control of shape, distribution and size of the fabricated 
particles, which proved to play important roles in the particle uptake by targeted cells and 
also the amount and speed of drug release.  The cytotoxicity study indicated the non toxic 
nature of the particles and the cellular uptake study was similar to the reported literature. 
The 2 µm sized amine containing elastomeric particle showed pH sensitive drug release 
at pH 5 and pH 7.5 buffers for Doxorubicin (DOX), a widely used anticancer drug, where 
DOX released faster in pH 7.5 buffer than it did in pH 5 buffer with the cumulative 
release of 72% in pH 7.4 buffer after the 82 h study. The incorporation of disulfide 
crosslinker switched the drug release properties in the other direction, which released 
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more DOX in pH 5 than pH 7.4 buffers. At the same time, Minocycline hydrochloride 
(MCH), which is an antibiotic and useful in the treatment of a host of topical bacterial 
infections, was studied as the model of hydrophilic drugs. We fabricated the similar drug 
loaded particles and studied the release of MCH in different buffers. The release of MCH 
in pH 5 showed burst release and then stabilized around 59%. But for the release in pH 
7.4 buffer, the MCH release showed a controlled and gradual release profile, which is 
promising for use as a drug release carrier. Moreover, our particle fabrication avoids 
using any aqueous medium, making it a more appropriate vehicle for MCH because the 
absence of moisture in the matrix would prevent MCH degradation. Still, the release of 
MCH in pH 7.4 can be further carried out to study the long term release, and the 
cumulative amount since our preliminary experiment was carried out in 2 days. 
To further explore the application of these particles as drug release carriers, it is 
possible to tune the size and shape of these particles to study the dependence of drug 
release on the physical structure of the particles. Also, the formulation of the particles can 
be adjusted to meet different requirements and to further study the influence of the 
disulfide crosslinker incorporation on the reducing agent sensitive release.  
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SUPPLEMENTAL MATERIALS FOR CHAPTER 2 
 
  128 
ppm (t1)
1.502.002.503.003.504.004.505.005.506.006.507.007.508.008.50
 
 
OH-AA-TEG-OH-2K
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ppm (t1)
1.502.002.503.003.504.004.505.005.506.006.507.007.508.00
 
 
AA-TEG-2K 
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ppm (t1)
1.001.502.002.503.003.504.004.505.005.506.006.507.007.508.00
 
 
AA-DEG-4K-THF 
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ppm (f1)
1.001.502.002.503.003.504.004.505.005.506.006.507.007.508.00
  
 
HO-DEG-AA-OH-4K 
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DEG-1K  
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DEG-2K 
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DEG-4K
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DEG-7K 
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TEG-1K 
  137 
 
 
 
TEG-2K 
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TEG-4K 
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TEG-7K 
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DEG-7K-Prepolymer 
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DEG-7K-elastomer
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TEG-1K-Prepolymer 
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TEG-7K-Prepolymer
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SUPPLEMENTAL MATERIALS FOR CHAPTER 3 
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SUPPLEMENTAL MATERIALS FOR CHAPTER 4
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ppm (t1)
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Elastomer, PIP:DEG=40:10 
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ppm (t1)
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Elastomer, PIP:DEG=20:30, 2K 
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ppm (t1)
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Elastomer, PIP:DEG=20:30, 1K 
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Elastomer, PIP:DEG=20:30, 6K 
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HO-PIP-AA-DEG-OH,  PIP:DEG=20:30, 6K
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ppm (t1)
1.502.002.503.003.504.004.505.005.506.006.507.00
10
.00
37
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Elastomer, PIP:DEG=10:40 
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ppm (t1)
1.001.502.002.503.003.504.004.505.005.506.006.507.00
24
.23
30
.00
 
 
 
Elastomer, PIP:DEG=30:20 
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ppm (t1)
1.02.03.04.05.06.07.08.0
 
 
Disulfide crosslinker 
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HO-PIP-AA-DEG-OH,  PIP:DEG=20:30, 3K 
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PIP:DEG=20:30, 3K 
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PIP:DEG=20:30, 6K
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PIP:DEG=20:30, 3K 
  170 
 
 
 
PIP:DEG=20:30, 6K  
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PIP:DEG=40:10 
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pKa of amino polyester 
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Disulfide containing elastomers degradation in 1 wt % NaBH4 for 0 day, 1 day, 3 day and 
in water. 
 
0 1 3 w
  174 
1 2 3
0
50
100
150
200
250
300
350
 
W
ei
gh
t L
o
ss
(%
)
W
a
te
r 
Up
ta
ke
 
(%
)
Time (Day)
 pH5wateruptake
 pH7.4waterup
 NaBH4wateruptake
 pH5degradation
 pH7.4degradation
 NaBH4degradation
 
Percentage of water uptake and weight loss against the experiment time in different 
media. (disulfide-amine containing elastomers) 
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Standard curve of Dox (500nm) in pH 5 buffer, UV-vis 
 
  
Concentration 
mg/mL 
Absorbance 
(OD) 
0.00344 0.0368 
0.006875 0.081 
0.01375 0.1698 
0.0275 0.339 
0.055 0.6891 
0.11 1.3598 
  
 
y = 12.421x - 0.0024
R2 = 0.9999
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
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Standard curve of Minocycline hydrochloride (350nm), HPLC 
 
 
 
Concentrations (µmol/L) Area (a.u.) 
0.1  
1  
5  
10 279743 
25  
50  
100 2498860 
200 4879613 
250  
400 9644892 
500 11438938 
600 13535596 
800 17988068 
1000 24566791 
 
 
MCH standard curve
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MCH release 
AU
0.0000
0.0001
0.0002
0.0003
0.0004
0.0005
Minutes
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00
 
PBS-1h
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AU
0.000
0.001
0.002
0.003
0.004
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2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00
 
 
PBS-20h, MCH release 
  179 
AU
0.000
0.001
0.002
0.003
0.004
0.005
Minutes
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00
 
 
PBS-44h ,MCH release 
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AU
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0.005
0.006
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Minutes
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00
 
 
pH 5 - 1h, MCH release 
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AU
0.000
0.005
0.010
0.015
0.020
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pH5-20h, MCH release 
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pH5-44h, MCH release 
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gluto- 1h ,MCH release 
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gluto-20h, MCH release 
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gluto-44h ,MCH release 
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2 micron Mold
  187 
 
 
Scum layer
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Mold filled with elastomers 
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Particles 
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Zeta potential of particles
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DOX loaded particles (2 micron) 
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MCH loaded particles- 2 micron 
 
 
 
 
